12th Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ
|
NCCIH, NCI, NHLBI, NIAAA, NIAID, NIDA, NIDDK, NIMH, NINR
|
2014
|
|
2024-2028 NIH-Wide Strategic Plan on Research on the Health of Women
|
Other
|
AHRQ, CDC, FDA, HRSA, OASH
|
CC, CSR, NCATS, NCCIH, FIC, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ AoU, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ OEPR, OD/ DPCPSI/ ONR, OD/ DPCPSI/ SGMRO
|
2022
|
|
3D Bioprinted skin models for drug screening
|
Research Initiative
|
FDA
|
NCATS
|
|
|
4th National Conference on Advancing Early Psychosis Care in the United States: Harnessing Resiliency in a Changing World
|
Meeting/ Workshop
|
SAMHSA
|
|
2018
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
Research Initiative
|
FDA
|
NCI
|
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and prostate cancer
|
Research Initiative
|
CDC
|
|
2020
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and renal cell carcinoma
|
Research Initiative
|
CDC
|
|
2018
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and uterine and ovarian cancers
|
Research Initiative
|
CDC
|
|
2019
|
|
A nested case-control study of serum PFAS and testicular cancer in Air Force servicemen
|
Research Initiative
|
CDC
|
|
2019
|
|
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
|
Research Initiative
|
CDC
|
|
1998
|
|
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A Working Group to Consider the Question of Federal Public Health and Medical Resource Allocation
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2011
|
|
A5349/TBTC S31 - Rifapentine - Containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-Label, Controlled Phase 3 Clinical Trial
|
Research Initiative
|
CDC
|
NIAID
|
2015
|
|
A5418: Study of Tecovirimat For Human Monkeypox Virus (STOMP)
|
Other
|
CDC, FDA
|
NIAID
|
2022
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Therapeutics Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-1: Immune Modulators (ACTIV-1)
|
Research Initiative
|
FDA, ASPR
|
NCATS
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-6: Outpatient Repurposed Drugs (ACTIV-6)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID, NHLBI, NCATS
|
2021
|
|
Accelerating Medicines Partnership (AMP)
|
Other
|
FDA
|
NIA, NIDDK, NIAMS, NINDS, NIMH
|
2014
|
|
Accelerating Medicines Partnership® Schizophrenia (AMP SCZ)
|
Research Initiative
|
FDA
|
|
2020
|
|
AccessGUDID
|
Resource Development
|
FDA, GDM
|
|
2015
|
|
ACL Advisory Council on Grandparents Raising Grandchildren
|
Committee, Advisory Group, or Work Group
|
ACL, ACF, SAMHSA, CDC, HRSA, ASPE, ONC
|
|
2019
|
|
Adaptive Optics Imaging of Outer Retinal Diseases
|
Research Initiative
|
FDA
|
|
|
|
Adaptive Optics Retinal Imaging
|
Research Initiative
|
FDA
|
NEI
|
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA, ASPR
|
NCI, NIAID
|
2013
|
|
Adolescent Brain Cognitive Development (ABCD) Study
|
Research Initiative
|
CDC
|
NCI, NIAAA, NICHD, NIDA, NIMH, NIMHD, NINDS, OD/ DPCPSI/ OBSSR
|
2016
|
|
Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
|
|
Adolescent Human Immunodeficiency Virus (HIV) Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
2016
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Advanced Viral Detection Technology IG (AVDTIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2018
|
|
Advancing American Kidney Health Initiative
|
Research Initiative
|
CDC, CMS, FDA, ASPE, ASPR, HRSA, IHS, OCR
|
NIEHS, NIDDK
|
2019
|
|
Advancing Protection and Care for Children in Adversity: A U.S. Government Strategy for International Assistance (APCCA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NICHD, NIMH
|
2019
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NHLBI
|
2003
|
|
Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NHGRI, NHLBI, NICHD, NIDDK, NLM
|
2015
|
|
Advisory Committee on Immunization Practices (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
|
|
Advisory Committee on Maternal/Pediatric RSV Vaccines (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, HRSA, IHS, CMS
|
NIAID
|
2022
|
|
Advisory Committee on Organ Transplantation (ACOT)
|
Committee, Advisory Group, or Work Group
|
HRSA, OS
|
NIAID
|
2009
|
|
Advisory Committee on RSV Vaccines in Older Adults (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, CMS
|
|
2022
|
|
Advisory Council on Blood Stem Cell Transplantation (ACBSCT) of the U.S. Department of Health and Human Services (HHS)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA
|
NHLBI
|
2008
|
|
Agency Priority Goals Maternal Health
|
Committee, Advisory Group, or Work Group
|
HRSA, NIH, ASPE, CDC, CMS, FDA, OASH, ACF, OGA, AHRQ, ACL
|
OD/ DPCPSI/ ORWH, NICHD, OD/ IMOD, OD/ DPCPSI/ OEPR
|
2022
|
|
Alaska Native Tumor Registry
|
Resource Development
|
CDC, IHS
|
|
1999
|
|
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
|
Research Initiative
|
FDA
|
NIAAA
|
|
|
All of Us IAA with CDC Office of Public Health Genomics
|
Other
|
CDC
|
|
2021
|
|
Alzheimers.gov Collaborations with Federal Agencies
|
Public Education Campaign
|
ACL, ASPA, ASPE, CDC
|
NIA, NINDS
|
2020
|
|
American Academy of Pediatrics (AAP) Committee on Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Nutrition
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Pediatric AIDS (AAP-COPA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Council on Genetics (AAP-COG)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Section on Obesity (AAP-SOO)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American Academy of Pediatrics Council on Injury, Violence and Poison Prevention (AAP-COIVPP)
|
Committee, Advisory Group, or Work Group
|
ACF, HRSA, IHS
|
NICHD
|
2011
|
|
American Community Survey (ACS) Interagency Committee Meeting
|
Meeting/ Workshop
|
ACF, AHRQ, ASPE, CDC, CMS, HRSA
|
NICHD
|
|
|
American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
Americas Children Forum on Health and Family Statistics
|
Resource Development
|
SAMHSA
|
NIDA
|
1994
|
|
AMP Bespoke Gene Therapy Program/Bespoke Gene Therapy Consortium (BGTC)
|
Research Initiative
|
FDA
|
NCATS, NHLBI, NIMH, NINDS
|
2019
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION)
|
Research Initiative
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
2011
|
|
Analytical Methods and Reference Materials Program (AMRM)
|
Resource Development
|
FDA
|
NCCIH, NCI, NIDDK
|
2002
|
|
Ancillary Swab Study to PREVENT-19 trial: Swab your Nose Inside to Find inFection (SNIFF)
|
Research Initiative
|
ASPR, CDC, FDA
|
|
2021
|
|
Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ, CDC
|
FIC, NHGRI, NHLBI, NIAAA, NIDA, NIDDK, NIMH, NIMHD, NINR, NIEHS, OD
|
2014
|
|
Antibody Interest Group (ABIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NIAID, NIDCR, NIDDK
|
2010
|
|
Antimicrobial Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2007
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC
|
NICHD
|
1989
|
|
Antiviral Program for Pandemics
|
Research Initiative
|
ASPR
|
NIAID, NCATS, OD/ DPCPSI/ ORIP
|
2020
|
|
Arthritis Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
Assay optimization and screening for measuring the kinetics of antibacterial resistance emergence
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Assay subgroup for SARS-CoV-2
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, BARDA, FDA
|
NIAID
|
2020
|
|
Assessing the Burden of Diabetes by Type in Children, Adolescents, and Young Adults Network (DiCAYA)
|
Resource Development
|
CDC
|
|
2020
|
|
Assessment of Inhalation Exposures to Indoor and Occupational Aerosols
|
Research Initiative
|
CDC
|
NIEHS
|
2014
|
|
Assessment of task-based exposures that may affect reproductive health in nail salon employees
|
Research Initiative
|
CDC
|
|
2021
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
Bacteriophage Interest Group (BIG)
|
Other
|
FDA
|
NIAID
|
|
|
BARDA-DRIVe (DRIVE)
|
Research Initiative
|
ASPR
|
NIAID
|
2022
|
|
Behavioral Health Coordinating Council (BHCC) Children and Youth Behavioral Health Subcommittee
|
Committee, Advisory Group, or Work Group
|
ACF, CMS, ACL, AHRQ, FDA, IHS, ASPE, CDC, OASH
|
NICHD, NIMH, NIDA
|
2021
|
|
Behavioral Health Coordinating Council (BHCC) Performance Measures, Data, and Evaluation Subcommittee (MDE)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASPE, CDC, CMS, FDA, IHS, NIH, ONC, SAMHSA
|
NIDA, NIMH
|
2021
|
|
Bench to Bedside: Integrating Sex and Gender to Improve Human Health
|
Resource Development
|
FDA
|
|
2017
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NICHD
|
2009
|
|
Best Pharmaceuticals for Children Act (BPCA) Research Oversight Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NHLBI, NCI
|
|
|
Best Pharmaceuticals for Children Act (BPCA) Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NHLBI, NCI
|
|
|
Biodefense Coordination Team (BCT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
2019
|
|
Biodosimetry Trans-NIH Working Group and Special Journal Issue
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
|
2019
|
|
Biomarkers of Exposure and Effect in Agriculture (BEEA)
|
Research Initiative
|
CDC
|
|
2018
|
|
Biomarkers of Exposure and Effect in Agriculture (Water Contaminants)
|
Research Initiative
|
CDC
|
|
2019
|
|
Biomedical Studies and Cellular Imaging via Atomic Force Microscopy
|
Research Initiative
|
FDA
|
NIBIB
|
|
|
Blood Products Advisory Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NHLBI
|
2011
|
|
Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
CC, NIAID7, NHLBI
|
2012
|
|
Board of Scientific Counselors (BSC) of the CDC National Center for Injury Prevention and Control
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, HRSA, IHS, SAMHSA
|
NIA, NICHD, NIDA, NIMH
|
2011
|
|
Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
Botanical Safety Consortium
|
Research Initiative
|
FDA
|
NCCIH
|
2019
|
|
Botulism Guidelines Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2016
|
|
Brain Attack Coalition (BAC)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NINDS
|
1997
|
|
Brain Research through Advancing Innovative Neurotechnologies Initiative (BRAIN Initiative)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NEI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIMH, NINDS, OD/ DPCPSI/ OBSSR
|
2014
|
|
BRIDG Standard Development
|
Research Initiative
|
FDA
|
|
2004
|
|
Bridge to Artificial Intelligence (Bridge2AI)
|
Research Initiative
|
FDA
|
NLM, NEI, NHGRI, NCCIH, NIBIB, NICHD, NCATS, NIMH, NIMHD, NIAID, NCI, NIAMS, NINDS, NIDA, NIA, NIGMS, FIC, OD/ DPCPSI/ OBSSR, OD/ AoU, OD/ DPCPSI/ ODSS
|
2021
|
|
Build UP Trust Challenge Prize
|
Resource Development
|
CDC, HRSA, OASH
|
NIMHD, NCI, NIA, NIAID, NIEHS, NINDS, NCATS, NIAMS, NIBIB, NIDA, NICHD
|
2021
|
|
Canadian - U.S. Dietary Reference Intakes Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH
|
NIDDK, OD/ DPCPSI/ ODS
|
2005
|
|
Cancer Diagnostic Devices Interagency Task Force (CD2) - MOU among NCI, FDA, HRSA
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
|
2021
|
|
Cancer Moonshot Award
|
Research Initiative
|
OS
|
NCI, NIDCD
|
2019
|
|
CCDI Molecular Target Platform
|
Resource Development
|
FDA
|
|
2021
|
|
CCR Vaccine Branch FACS Core
|
Research Initiative
|
FDA
|
NCI
|
|
|
CCR, LGI, Flow Cytometry Core
|
Research Initiative
|
FDA
|
NCI
|
|
|
CDC Acute Flaccid Myelitis Task Force
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NINDS
|
2018
|
|
CDC Integration with GrantSolutions
|
Resource Development
|
ACF, CDC
|
OD/ OER
|
2016
|
|
CDC Office of Public Health Genomics
|
Public Education Campaign
|
CDC
|
NHLBI
|
2017
|
|
CDC Pathogen Genomic Centers of Excellence (PGCoE)
|
Research Initiative
|
CDC
|
NIAID
|
2022
|
|
CDC-NIH Lyme Disease Serum Sample Repository
|
Resource Development
|
CDC, OS
|
NIAID
|
2008
|
|
CDC/NIH Quarterly Check-ins
|
Other
|
CDC
|
NIMH, NIAID
|
2021
|
|
Cell-Surface Interactions in Pathogenesis
|
Research Initiative
|
FDA
|
NIDCR
|
|
|
Center for Medicare and Medicaid Services (CMS) and National Institutes of Health (NIH) Opioids Work Group (OWG)
|
Committee, Advisory Group, or Work Group
|
CMS
|
NIDA, NCCIH, NINDS, NIMH
|
2018
|
|
Central Brain Tumor Registry of the United States (CBTRUS)
|
Research Initiative
|
CDC
|
|
2021
|
|
Cervical screening guidelines
|
Resource Development
|
CDC, HRSA, FDA
|
|
2019
|
|
CFAR Diversity, Equity, Inclusion Pipeline Initiative (CDEIPI)
|
Research Initiative
|
OASH
|
NIAID, NIMH, NCI, NHLBI, NIDDK, NINR, NIDCR, NIMHD, NICHD, NIA, FIC, OD/ DPCPSI/ OAR
|
2021
|
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
2009
|
|
Chemical Hazards Emergency Medical Management (CHEMM) Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC
|
NLM, NICHD
|
2010
|
|
Chronic Kidney Disease Surveillance System
|
Health Survey
|
CDC
|
NIDDK
|
2006
|
|
Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort
|
Research Initiative
|
CDC
|
|
2018
|
|
CLARITY - Mammary Gland efforts
|
Research Initiative
|
ATSDR
|
NIEHS
|
2016
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS
|
2012
|
|
Clinical and Translational Serology Task Force (CTTF)
|
Resource Development
|
CDC, FDA, ASPR
|
NIAID
|
2021
|
|
Clinical Genome Resource and Genetic Testing Reference Material Program Collaborative Project (ClinGen and GeT-RM Collaborative Project)
|
Resource Development
|
CDC
|
|
2021
|
|
Clinical Immunization Safety Assessment Network (CISA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NHLBI
|
2021
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Pharmacology Quality Assurance Program (CPQA)
|
Other
|
CDC
|
NIAID
|
2021
|
|
Clinical Research Using Medicare Data from the Virtual Research Data Center (VRDC)
|
Research Initiative
|
CMS
|
NLM
|
2016
|
|
Clinical Trials of Biodefense Vaccines (Dengue)
|
Research Initiative
|
CDC
|
NIAID
|
|
|
Clinical Utilization Plan for Anthrax Medical Countermeasure Use in a Mass Casualty Event (CUPAC) Medical Countermeasures Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2013
|
|
Clinical Vocabulary and Standards Development for Meaningful Use of Electronic Medical Records
|
Resource Development
|
CDC, CMS, FDA, ONC
|
NLM
|
2008
|
|
CMS MCBS, Dietary Supplements, Measures of Malnutrition and Frailty
|
Health Survey
|
CMS
|
|
2019
|
|
CMS-NIH Leadership Council
|
Committee, Advisory Group, or Work Group
|
CMS
|
NCCIH, NCI, NHGRI, NHLBI, NIA, NIDA, NIDDK, NIMHD, OD/ IMOD, OD/ OER, OD/ OSP
|
2011
|
|
CMS/NIH/NHLBI Sickle Cell Disease Working Group
|
Meeting/ Workshop
|
CMS
|
|
2021
|
|
Collaborative Acute Toxicity Modeling Suite (CATMoS)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NCATS
|
2018
|
|
Collaborative on Healthy Parenting in Primary Care
|
Public Education Campaign
|
CDC, HRSA, SAMHSA
|
NICHD
|
|
|
Combating Antibiotic Resistant Bacteria (CARB)
|
Resource Development
|
CDC, FDA
|
NHGRI, NIAID
|
2015
|
|
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Joint Oversight Committee (CARBx-JOC)
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC
|
NIAID
|
2016
|
|
Combined Exposures and Mixtures Research Program
|
Research Initiative
|
ATSDR, CDC, FDA, OASH
|
NIEHS
|
|
|
Commissioned Corps of the U.S. Public Health Service (USPHS) Oral Health Coordinating Committee (OHCC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, OASH, IHS, SAMHSA
|
|
1990
|
|
Community Guide Cardiovascular Coordination Team
|
Committee, Advisory Group, or Work Group
|
CDC
|
NHLBI
|
2013
|
|
Community Preventive Services Task Force (CPSTF)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, AHRQ, OASH, HRSA, IHS, SAMHSA
|
OD/ DPCPSI
|
1996
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC, OD/ OIR
|
2004
|
|
Congenital Heart Public Health Consortium
|
Resource Development
|
AHRQ, CDC
|
NHLBI
|
2008
|
|
Consumer Product Chemical Exposures in Pregnancy and Their Cumulative Impact on Disorders of Fetal Growth
|
Research Initiative
|
CDC
|
|
2020
|
|
Contract to fund Congressional mandated National Academies of Sciences, Engineering, and Medicine (NASEM) study on Organ Donation and Transplantation
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NHLBI, NIAID, NIDDK
|
2019
|
|
Coordinating Committee on Research on Women's Health (CCRWH) Sex, Gender, and Intersectionality (SG&I) Innovations Working Group (CCRWH SG&I Innovations WG)
|
Research Initiative
|
FDA, AHRQ, Other
|
OD, NIA, NHLBI, OD/ AoU, NIGMS, NICHD, NCI, NINDS, NIBIB, NCCIH, NIDA
|
2022
|
|
COPD National Action Plan
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, HRSA, IHS
|
NCI, NHLBI, NIA, NIEHS, NINR
|
2017
|
|
Countering Biothreats IPC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countering Biothreats sub-IPC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countermeasures Against Chemical Threats program (CounterACT)
|
Research Initiative
|
ASPR
|
NIAID, NIAMS, NICHD, NEI, NINDS, NIDA
|
2006
|
|
Country Work in Cancer Research and Cancer Control Planning Strengthening – Kenya
|
Research Initiative
|
CDC
|
FIC, NIAID
|
2013
|
|
COVID antibody testing
|
Research Initiative
|
ASPR
|
NIAID
|
2020
|
|
Covid Serology Research and Results Tracker (SeroHub)
|
Resource Development
|
CDC
|
NIAID
|
2020
|
|
COVID-19 and Influenza Scenario Modeling Hubs (SMH)
|
Research Initiative
|
CDC
|
NIGMS
|
2020
|
|
COVID-19 Health and Safety Briefs
|
Training Initiative
|
CDC
|
|
2021
|
|
COVID-19 OpenData Portal
|
Research Initiative
|
ASPR
|
NCATS, NIAID, NLM
|
2020
|
|
COVID-19 Therapeutics Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIAID
|
2020
|
|
Critical Path for Rare Neurodegenerative Diseases (CP-RND)
|
Research Initiative
|
FDA
|
|
2022
|
|
CTAC Ad hoc Strategic Planning Working Group (CTAC SPWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CMS
|
|
2019
|
|
CTAC ad hoc Working Group on Streamlining Clinical Trials (CTAC SCTWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2022
|
|
CURE ID
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
CURE ID App for Infectious Disease Case Reporting
|
Research Initiative
|
FDA
|
NCI
|
|
|
Cytokine Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NEI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCR, NIDCD
|
2007
|
|
DailyMed
|
Resource Development
|
FDA
|
|
2005
|
|
Data Access for Grantees
|
Resource Development
|
CMS
|
NIA
|
2010
|
|
Department of Defense Resuscitation and Transfusion Steering Committee
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NHLBI
|
2012
|
|
Department of Health and Human Services (DHHS) Guidelines for Treatment of HIV Related Opportunistic Infections Among Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, OD/ DPCPSI/ OAR
|
1989
|
|
Department of Health and Human Services (DHHS) Health Care Personnel Influenza Vaccination Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2008
|
|
Department of Health and Human Services (DHHS) Healthcare Infection Control Practices Advisory Committee (HICPAC)
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2005
|
|
Department of Health and Human Services (DHHS) Medical Claims Review Panel
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
|
1990
|
|
Department of Health and Human Services (DHHS) Steering Committee for the Prevention of Healthcare-Associated Infections
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2008
|
|
Department of Health and Human Services (HHS) Biovigilance Committee
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NHLBI
|
2009
|
|
Department of Health and Human Services AAPI Memorandum Workgroup
|
Meeting/ Workshop
|
AHRQ, FDA, OASH, CDC, ASFR, ASPE, CMS
|
|
2021
|
|
Development of New Approach Methodologies to Reduce Animal Use in Toxicity Testing -SBIR/STTR Town Hall Meeting
|
Meeting/ Workshop
|
FDA
|
|
2020
|
|
Development Of New Approaches To Vaccines Against Neurotropic Flaviviruses
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Development testing of nucleic acid-based vaccine for HIV other indications
|
Research Initiative
|
FDA
|
NCI
|
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OASH
|
NIDDK
|
1974
|
|
Diabetes Prevention Program Outcomes Study (DPP/DPPOS)
|
Research Initiative
|
CDC
|
NCI, NHLBI, NIA
|
1994
|
|
Diabetic Eye Disease Information Dissemination
|
Public Education Campaign
|
CDC
|
NEI
|
2015
|
|
Diagnosis, Treatment, and Medical Service Utilization in Medicare and Medicaid Population
|
Research Initiative
|
CMS
|
|
2011
|
|
Diagnostics and Disease Management Tools for Use in Underserved Populations: An NHLBI Research & Implementation Workshop
|
Meeting/ Workshop
|
AHRQ, CMS, CDC, FDA, OASH, HRSA, IHS
|
NCATS, NIMHD, NIBIB
|
2021
|
|
Diet Induced Hypomethylation in Preneoplastic Liver
|
Research Initiative
|
FDA
|
|
2004
|
|
Dietary Supplement Label Database (DSLD)
|
Resource Development
|
FDA, CDC
|
NLM, OD/ DPCPSI/ ODSS, NCCIH, NCI
|
2004
|
|
Dietary Supplement Relevant - Special Interest Databases (purines, nitrates/nitrates)
|
Resource Development
|
FDA
|
|
2016
|
|
Dietary Supplement Research Coordination Committee (DSRCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ONR
|
2022
|
|
Digestive Diseases Interagency Coordinating Committee (DDICC)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
NCI, NIBIB
|
1985
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
|
2011
|
|
Drug Development Interest Group
|
Committee, Advisory Group, or Work Group
|
ASPR
|
FIC, NCI, NHLBI, NIAID
|
2015
|
|
Drug Induced Liver Injury Network (DILIN)
|
Resource Development
|
FDA
|
NCI, NIDDK
|
2003
|
|
EAGeR Trial - The Effects of Aspirin in Gestation and Reproduction Trial
|
Research Initiative
|
FDA
|
NICHD
|
|
|
Early Hearing Detection and Intervention
|
Meeting/ Workshop
|
CDC, HRSA
|
NIDCD
|
2007
|
|
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite with Coordinating Center
|
Research Initiative
|
HRSA
|
NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR
|
2019
|
|
Ebola Clinical Research Response in Democratic Republic of the Congo
|
Research Initiative
|
CDC, ASPR
|
NIAID
|
2018
|
|
Ebola Clinical Research Response in West Africa (Guinea, Liberia)
|
Research Initiative
|
CDC, FDA
|
NIAID
|
2014
|
|
Ebola Vaccines Advisory Committee on Immunization Practices (ACIP) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2020
|
|
ECHO Institute and Project ECHO for Cancer Research and Control
|
Other
|
CDC
|
|
2017
|
|
Effective Data Management Subgroup of the Open Science Infrastructure Working Group of the Subcommittee on Open Science of the National Science and Technology Council Subcommittee on Open Science (NSTC OSTP SOS-EDM)
|
Committee, Advisory Group, or Work Group
|
ACL, ASPR, CDC
|
OD/ OSP
|
2019
|
|
EHE Operations Leadership Team (OLT)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, HRSA, IHS, SAMHSA, CMS
|
NIAID, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
Emergency Preparedness, Medical Countermeasures (ASPR)
|
Resource Development
|
ASPR, CDC
|
|
2007
|
|
Emerging Contaminants and Issues of Concern Research Program
|
Research Initiative
|
CDC
|
NIEHS
|
|
|
Emerging Tobacco Products Communication Initiative Subject Matter Expert Work Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2021
|
|
End-stage Renal Disease Collaboration
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NIBIB, NIDDK
|
2016
|
|
Ending the HIV Epidemic in the US administrative supplement announcement for NIH Centers for AIDS Research and NIMH AIDS Research Centers
|
Research Initiative
|
CDC, HRSA, Other
|
NIAID, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID, NICHD
|
2003
|
|
Enhanced Federal Collaborations in Implementation Science and Research of HIV Prevention and Treatment
|
Other
|
CDC, HRSA
|
NIAID, NIMH
|
2022
|
|
Enhancing Scientific Collaboration between US and Colombia
|
Committee, Advisory Group, or Work Group
|
OGA
|
NIAID, FIC
|
2021
|
|
Environmental Phthalate Exposures In Pregnancy in Relation to Fetal and Placental Development
|
Research Initiative
|
CDC
|
|
2020
|
|
Epidemiology, immunology, and evolution of SARS-CoV-2 and other coronaviruses before and during the COVID-19 pandemic
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
eRA Federal Shared Services (eRA)
|
Resource Development
|
AHRQ, FDA, SAMHSA, ASFR
|
OD/ OER
|
2016
|
|
Establishment of representative examination and dose repository for patients undergoing interventional fluoroscopic procedures
|
Research Initiative
|
FDA
|
|
2021
|
|
Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO RGN)
|
Research Initiative
|
HRSA
|
NHGRI
|
2021
|
|
Evaluation of Oropharyngeal responses to SARS-CoV-2
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
Evaluation of the safety, tolerability, pharmacokinetics, and pharmacodynamics of long-term mitapivat dosing in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
Evaluation of Visual Function in Animal Models
|
Research Initiative
|
FDA
|
NEI
|
|
|
Evidence-Based Cancer Control Programs (EBCCP)
|
Resource Development
|
CDC
|
|
2003
|
|
Extracorporeal CPR (ECPR) for Out-of-hospital Cardiac Arrest
|
Meeting/ Workshop
|
OASH
|
|
2021
|
|
Factor VIII Inhibitors: Generating a National Blueprint for Future Research
|
Meeting/ Workshop
|
CDC
|
NCI, NHLBI, NICHD, NLM
|
2017
|
|
FDA Antimicrobial Drugs Advisory Committee (FDA AMDAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2021
|
|
FDA CDER & NIH NCATS Regulatory Fitness in Rare Disease Clinical Trials Workshop
|
Meeting/ Workshop
|
FDA
|
NCATS
|
2022
|
|
FDA Collaboration - Psilocybin Research
|
Research Initiative
|
FDA
|
|
2020
|
|
FDA Microbiology Devices Panel of the Medical Devices Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
FDA-NCI Quarterly Meeting
|
Meeting/ Workshop
|
FDA
|
|
1991
|
|
FDA-NIH Joint Leadership Council
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIDA, NIDDK, NINDS, OD/ IMOD, OD/ OER, OD/ OSP
|
2010
|
|
FDA/NIMH Points of Contact Working Group Meeting - Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2020
|
|
Feasibility Study: Maternal Health Care of Pregnant Women in Custody, Expert Panel
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NICHD
|
|
|
Federal Cannabis Partners
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
NIDA, NCI
|
|
|
Federal Cervical Cancer Collaboration
|
Resource Development
|
HRSA
|
OD/ DPCPSI/ ORWH
|
2020
|
|
Federal Data Consortium on Pregnancy and Birth to 24 Months
|
Resource Development
|
CDC, FDA, OASH
|
NCATS, NCI, NHLBI, NIAID, NICHD, NIDDK, NIEHS, NIMHD, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ONR, OD/ DPCPSI/ ORWH, OD/ ECHO
|
2016
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH, ACL
|
NHLBI, NIDDK
|
2005
|
|
Federal Experts Security Advisory Panel (FESAP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2010
|
|
Federal Health IT Coordinating Council
|
Committee, Advisory Group, or Work Group
|
CMS, ACF, AHRQ, CDC, FDA, HRSA, IHS, OASH, ASA
|
NHGRI, OD/ OSP
|
2004
|
|
Federal HIV Implementation Science Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA
|
NIAID, NIDA, OD/ DPCPSI/ OAR
|
2018
|
|
Federal HIV Web Council (HIV.gov) (FHWC)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, FDA, HRSA, IHS, SAMHSA, ACF
|
NIAID, NIDA, OD/ DPCPSI/ OAR
|
2006
|
|
Federal Hypertension Control Leadership Council
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, ASPR, ONC
|
NHLBI, NINDS
|
2020
|
|
Federal Implementation Science Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NIAID, NIMH, NIDA, OD/ DPCPSI/ OAR
|
2018
|
|
Federal Interagency Breastfeeding Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2009
|
|
Federal Interagency Forum for Child and Family Statistics
|
Research Initiative
|
ACF, AHRQ, CDC, HRSA, OS, SAMHSA
|
NICHD, NIMH
|
2010
|
|
Federal Interagency Forum on Aging Related Statistics
|
Resource Development
|
ACL, AHRQ, CDC, CMS, OS, SAMHSA
|
NIA
|
1986
|
|
Federal Interagency Task Force on the Arts and Human Development
|
Research Initiative
|
ACF, ACL, SAMHSA
|
NCCIH, NCI, NIA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2011
|
|
Federal Interagency Traumatic Brain Injury Research Working Group (FITBIR Working Group)
|
Resource Development
|
AHRQ, CDC, HRSA, OS, SAMHSA
|
CIT, NCATS, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIGMS, NIMH, NINDS
|
2008
|
|
Federal Interagency Workgroup on Autism Spectrum Disorders (FIWA)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, CMS, HRSA, IHS, SAMHSA, ASPE, ACF, FDA
|
NINDS, NICHD
|
2018
|
|
Federal Interagency Workgroup on Child Abuse and Neglect (FEDIAWG)
|
Committee, Advisory Group, or Work Group
|
ACF
|
NIAAA, NICHD, NIDA, NIMH, OD/ DPCPSI/ OBSSR
|
1998
|
|
Federal Interagency Workgroup on Improving Diagnostic Safety and Quality in Health Care
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, ONC, SAMHSA, OASH, CMS
|
NIBIB, NLM, NCI, NCATS
|
2018
|
|
Federal Interagency Workgroup on Intellectual Disabilities/Developmental Disabilities (ID/DD) Administrative Data (FIW IAD)
|
Committee, Advisory Group, or Work Group
|
ACL, CMS, ASPE, CDC, HRSA, AHRQ, SAMHSA
|
NICHD, NIMH
|
2020
|
|
Federal Interagency Workgroup on Teen Dating Violence
|
Committee, Advisory Group, or Work Group
|
ACF, CDC
|
NICHD
|
2006
|
|
Federal Interagency Working Group on Measuring Sexual Orientation and Gender Identity (FIW SOGI)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CMS, SAMHSA
|
NICHD, OD/ DPCPSI/ SGMRO
|
2015
|
|
Federal Interagency Workshop: Nonhuman Primate Resources and Needs for Biomedical Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
OD/ DPCPSI/ OAR, OD/ OIR, OD/ ORS, OD/ OSP, CC, NCCIH, NEI, NHLBI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIMH, NINDS
|
2021
|
|
Federal Lead Action Plan Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
|
|
|
Federal Partners in Bullying Prevention, Intervention, and Recovery
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, IHS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH, OD/ DPCPSI/ OBSSR
|
2010
|
|
Federal Sudden Unexpected Infant Death/Sudden Infant Death Syndrome (SUID/SIDS) Workgroup
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, IHS
|
NICHD
|
2009
|
|
Federal Supply and Demand of Isotopes
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB
|
2012
|
|
Federal Tuberculosis (TB) Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NIAID, NICHD
|
1991
|
|
Federal Work Group on Suicide Prevention
|
Committee, Advisory Group, or Work Group
|
SAMHSA, CDC, IHS, ACF, ACL, AHRQ, HRSA, ASPE
|
NIDA, NIMH, NIAAA
|
|
|
Federal Working Group on Bone Diseases
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
CSR, NCATS, NCI, NIA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, OD/ DPCPSI/ ORWH, NIAAA
|
1993
|
|
Federal Working Group on Dietary Supplements (FWGoDS)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, IHS
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ONR, OD/ DPCPSI/ ORWH
|
2005
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG) Workshop
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
2018
|
|
FNIH Advanced Medicines Partnership® - Bespoke Gene Therapy Consortium (FNIH AMP BGTC)
|
Research Initiative
|
FDA
|
NCATS
|
2019
|
|
FNIH Biomarkers Consortium (FNIH)
|
Research Initiative
|
CMS, FDA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NINDS
|
2006
|
|
Focus on Aging: Federal Partners Webinar Series
|
Public Education Campaign
|
ACL, CDC, HRSA
|
NIA
|
2017
|
|
Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Foundation for the National Institutes of Health (FNIH) PACT (Partnership for Accelerating Cancer Therapies) (FNIH PACT)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2017
|
|
Full-text health-related documents at NLM (includes HSTAT) Bookshelf/Digital Repository
|
Resource Development
|
AHRQ, ATSDR, CDC, CMS, FDA, SAMHSA
|
|
1994
|
|
Functional and Structural Optical Brain Imaging
|
Research Initiative
|
FDA
|
NICHD
|
|
|
Funding Opportunity Announcement Module (FOAM)
|
Resource Development
|
ACF, ACL, AHRQ, CDC, CMS, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ AoU, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC, OD/ DPCPSI/ THRO, OD/ DPCPSI/ SGMRO, OD/ ECHO, OD/ IMOD, OD/ OCPL, OD/ OER, OD/ OIR, OD/ OIR/ OTT, OD/ OLPA, OD/ OM/ OB, OD/ ORS, OD/ OSP
|
2016
|
|
FY 22 Ending the HIV Epidemic in the US Funding Opportunity Announcement
|
Research Initiative
|
CDC, HRSA
|
NIAID, NIMH, NIDA
|
2022
|
|
Gabriella Miller Kids First Common Fund Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NINDS, OD/ DPCPSI/ ORIP
|
2015
|
|
Gender Policy Council: HHS Women's Health & Rights Working Group
|
Committee, Advisory Group, or Work Group
|
SAMHSA, HRSA, CDC, OGA, OASH
|
NICHD
|
|
|
Genetic Epidemiology of Diabetes and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Genetic Epidemiology of Diabetic Complications
|
Research Initiative
|
IHS
|
|
|
|
Genetic Studies in the National Birth Defects Prevention Study (NBDPS)
|
Research Initiative
|
CDC
|
NHGRI
|
2014
|
|
Genital Herpes Workshop
|
Meeting/ Workshop
|
CDC
|
NIAID
|
2022
|
|
Genome in a Bottle Consortium (GIAB)
|
Resource Development
|
CDC, FDA
|
NHGRI, NCI
|
2013
|
|
Genomic epidemiology of norovirus GII.4 globally
|
Research Initiative
|
FDA
|
|
2022
|
|
Global Burden of Disease U.S. Health Disparities Working Group
|
Resource Development
|
CDC
|
NHLBI, NCI, NIA, OD/ DPCPSI/ OBSSR, NIAMS
|
|
|
Global Environmental and Occupational Health (GEOHealth)
|
Research Initiative
|
CDC
|
FIC, NCI, NIEHS, OD/ DPCPSI/ ORWH
|
2011
|
|
Global Health Security Agenda (GHSA) Action Package Prevent 3 (APP3), Biosafety and Biosecurity Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
OD/ OSP
|
2014
|
|
Global Initiative for Cancer Registry Development (GICR)
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2014
|
|
Global Nutrition Coordination Plan (GNCP)
|
Committee, Advisory Group, or Work Group
|
CDC, OGA, FDA
|
NICHD, NCI
|
2016
|
|
Global Substance Registration System (GSRS)
|
Research Initiative
|
FDA
|
NCATS, OD/ OIR
|
2013
|
|
GlycoBiology Scientific Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Government-University-Industry Research Roundtable (GUIRR)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ IMOD, NCATS
|
|
|
H-CORE
|
Committee, Advisory Group, or Work Group
|
ASPR/BARDA
|
NIAID
|
2022
|
|
Harmonization of Various Common Data Models and Open Standards for Evidence Generation (CDMH II)
|
Resource Development
|
FDA
|
NCATS, NCI, NLM
|
2016
|
|
HDPulse Dissemination and Adaptation Working Group
|
Resource Development
|
OASH
|
|
|
|
Health and Retirement Study (HRS)
|
Research Initiative
|
CDC, CMS
|
NIA
|
1992
|
|
Health Information Technology Advisory Committee (HITAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, ONC
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS
|
2014
|
|
Health Promotion Activity to Recognize National Minority Health Month
|
Public Education Campaign
|
OASH
|
NIMHD
|
2022
|
|
Healthy People 2020/2030 Heart Disease and Stroke Federal Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NHLBI, NINDS
|
2010
|
|
Healthy People 2030 - Chronic Kidney Disease Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, OS, OASH
|
|
1998
|
|
Healthy People 2030 - Heart Disease and Stroke Workgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OS
|
NHLBI, NINDS
|
2000
|
|
Healthy People 2030 - Nutrition and Weight Status Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, Other
|
NIDDK
|
2010
|
|
Healthy People 2030 - Respiratory Diseases
|
Health Survey
|
CDC
|
NHLBI, NIA, NICHD, NIDA, NIDDK, NIMHD, NINDS, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS
|
2000
|
|
Healthy People 2030 - Sleep Health
|
Health Survey
|
CDC
|
NHLBI, NIA, NICHD, NIDA, NIDDK, NIMHD, NINDS, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS
|
2000
|
|
Healthy People 2030 - Social Determinants Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, OASH, SAMHSA, PSC, FDA
|
NIA, NCI, NIAAA, NIMHD
|
2016
|
|
Healthy People 2030 Chronic Pain Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, OASH
|
|
2020
|
|
Healthy People 2030 Disability and Health Work Group
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NICHD
|
|
|
Healthy People Initiative
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDCD, NIDDK, NIEHS, NIMH, NINDS
|
1979
|
|
Healthy People Initiative - Visual Health
|
Health Survey
|
AHRQ, CDC
|
NEI
|
2011
|
|
Healthy Vision Month
|
Public Education Campaign
|
CDC
|
NEI
|
2014
|
|
Heart Failure Collaboratory
|
Meeting/ Workshop
|
CMS, FDA
|
|
2017
|
|
Heart Valve Collaboratory
|
Meeting/ Workshop
|
CMS, FDA
|
|
2020
|
|
Helicobacter pylori Genome Project (HpGP)
|
Research Initiative
|
CDC
|
NLM
|
2016
|
|
Hepatitis B Research Network (HBRN)
|
Research Initiative
|
CDC
|
NCI, NIDDK
|
2008
|
|
HHS Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG)
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID, NIDA, NIDDK, NIMHD
|
2011
|
|
HHS Adolescent Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH
|
2010
|
|
HHS Adult Maltreatment Prevention Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA
|
NIA
|
2018
|
|
HHS Agency Priority Goal on Equity Workgroup (FY 2022-2023)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, CDC, CMS, HRSA
|
OD/ OEDI, NICHD, NIMHD
|
2021
|
|
HHS Antiretroviral Treatment Guidelines Panel for Adults and Adolescents with HIV
|
Committee, Advisory Group, or Work Group
|
HRSA, CDC, FDA
|
NIAID
|
1996
|
|
HHS Behavioral Health Coordinating Council (BHCC) Overdose Prevention Subcommittee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA, OASH, ASPE
|
NIDA, OD/ OSP
|
2009
|
|
HHS Behavioral Health Coordinating Council, Subcommittee on Children and Youth
|
Committee, Advisory Group, or Work Group
|
HRSA, SAMHSA, FDA, OASH, CMS
|
NICHD, NIMH, NIDA
|
|
|
HHS Biannual Dual Use Research of Concern (DURC) Inventory
|
Resource Development
|
CDC, FDA, OS
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OSP
|
2012
|
|
HHS Biosafety and Biosecurity Coordinating Council (HHS BBCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ ORS, OD/ OSP
|
2015
|
|
HHS Border Health Intra-agency Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, FDA, HRSA, OS
|
NIA, NIAID, NICHD, NIDDK, NIMH, NIMHD
|
2008
|
|
HHS Coordination Operations and Response Element (previously Operation Warp Speed) (H-CORE/OWS)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
HHS DATA Act Compliance
|
Committee, Advisory Group, or Work Group
|
ASFR
|
OD/ OM/ NBS
|
2020
|
|
HHS Data Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASFR, ASPA, ASPE, ASPR, ATSDR, CDC, CMS, FDA, GDM, HRSA, IHS, ONC, OMHA
|
NLM, NIGMS, OD/ DPCPSI/ OBSSR, OD/ OER, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ SGMRO
|
1996
|
|
HHS Data Governance Board
|
Committee, Advisory Group, or Work Group
|
OCIIO, ASPE, CDC, ACF, ACL, AHRQ, CMS, FDA, HRSA, IHS, SAMHSA, ASFR, ASPA, ASPR, OIG
|
OD/ OSP
|
2020
|
|
HHS Dietary Guidance Review Committee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OASH
|
NIDDK
|
1990
|
|
HHS Disability Collaborative
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPA, ASPE, ASFR, ASA, ASPR, ACF, CDC, CMS, OASH, OCR, ONC, OIG, OGA, HRSA, SAMHSA, FDA, IHS
|
NIA, NICHD
|
2020
|
|
HHS Ebola Medical Countermeasures Scientific Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, OGA, CDC, FDA
|
|
2018
|
|
HHS Environmental Justice and Natural Disasters Working Group (EJ)
|
Committee, Advisory Group, or Work Group
|
ASPR, OASH, CDC, HRSA
|
NIEHS
|
2012
|
|
HHS Environmental Justice Working Group (EJWG)
|
Committee, Advisory Group, or Work Group
|
OASH
|
NIEHS, OD/ DPCPSI/ SGMRO
|
2022
|
|
HHS Health Disparities Council
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIMHD
|
|
|
HHS HIV Bidirectional Meeting Planning Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAID, NIMH
|
2018
|
|
HHS LGBT Policies Coordinating Committee (HHS LGBT CC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIMH, OD/ DPCPSI/ SGMRO
|
2011
|
|
HHS Liaison to NASA
|
Other
|
FDA
|
NCATS, OD/ IMOD
|
2018
|
|
HHS Long COVID Working Group
|
Committee, Advisory Group, or Work Group
|
SAMHSA, AHRQ
|
NIDA, NIMH
|
2022
|
|
HHS Maternal Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASPE, ASFR, CDC, CMS, FDA, HRSA, IHS, ONC, IOS, ATSDR, SAMHSA
|
NICHD, OD/ DPCPSI/ ORWH, NHLBI
|
|
|
HHS Minority Health Offices Directors Committee
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, HRSA, IHS, FDA, SAMHSA
|
|
2020
|
|
HHS Noise-Induced Hearing Loss Federal Partner Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIDCD
|
2018
|
|
HHS Nutrition Working Group
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, NIH, OASH, SAMHSA, OS
|
NHLBI, NCI, OD/ DPCPSI/ ORWH
|
2021
|
|
HHS Office on Womens Health, Section on Pregnancy and Newborn Care
|
Committee, Advisory Group, or Work Group
|
OS, SAMHSA
|
NICHD, NIMH
|
|
|
HHS Panel for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
|
Committee, Advisory Group, or Work Group
|
CDC
|
NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Antiretroviral Guidelines for Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Potential Pandemic Pathogens Care and Oversight Review Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2018
|
|
HHS Privacy Committee
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OM
|
|
|
HHS Reproductive Health Care Access Task Force (HHS RATF)
|
Committee, Advisory Group, or Work Group
|
OASH, OCR, ASPE, AHRQ, CDC, HRSA, IHS
|
OD
|
2022
|
|
HHS SARS-CoV-2 Assay Development Task orders
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2020
|
|
HHS SARS-CoV-2 Immune Assay Testing of Ph3 clinical samples- Task Order
|
Resource Development
|
ASPR
|
NIAID
|
2020
|
|
HHS Smoking Cessation Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI
|
2021
|
|
HHS Social Determinants of Health Workgroup
|
Committee, Advisory Group, or Work Group
|
ACL, ACF, AHRQ, CDC, HRSA, IHS, OASH, FDA, CMS, SAMHSA
|
NIA, NICHD
|
2019
|
|
HHS Strategic Plan FY 2022-2026: Subcommittee for Objective 3.4
|
Committee, Advisory Group, or Work Group
|
ASFR, CDC, ACF, SAMHSA, HRSA, ACL, ASPE
|
NICHD, NIMH
|
|
|
HHS Tick-Borne Diseases Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
NIAID
|
2017
|
|
HHS Tobacco Control Steering Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, SAMHSA, OS
|
NCI, NIDA
|
2021
|
|
HHS Viral Hepatitis Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA, OASH, ONC
|
NIDA, OD/ DPCPSI/ OAR, NIAID, NIDDK
|
2009
|
|
HHS-Wide Stigma Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, IHS, SAMHSA
|
|
2019
|
|
HHS/Office of the Secretary, Office of the Assistant Secretary for Planning and Evaluation (OS-ASPE) - Reentry/Criminal Justice Working |Group.
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, HRSA, SAMHSA
|
NHLBI, NIDA, NIMH
|
2017
|
|
HIV/AIDS Cancer Match Study (HACM)
|
Research Initiative
|
CDC
|
|
1992
|
|
Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings
|
Research Initiative
|
AHRQ
|
|
2010
|
|
Host Immune Responses to Antigens of Malaria Parasites
|
Research Initiative
|
FDA
|
NIAID
|
|
|
HRSA Advancing Precision Medicine (HRSA APM)
|
Other
|
HRSA
|
|
2017
|
|
Human skin sensitization data set
|
Research Initiative
|
FDA
|
|
2020
|
|
Human Specimen Collection to Support Basic and Clinical Research
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
I-Corps @ NIH
|
Training Initiative
|
CDC
|
NCATS, NCCIH, NHGRI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NINDS
|
2015
|
|
IAA with FDA - Using big data to compare SARS-CoV-2 infection and therapeutic efficacy between human lung on a chip and animal model testing
|
Other
|
FDA
|
NIAID
|
2020
|
|
ICCFASD SBI Working Group for Pregnant and Postpartum People (ISBI-WG) (ISBI)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, CDC, CMS, IHS, HRSA, SAMHSA
|
NIDA
|
2021
|
|
ICCFASD Strategic Planning Working Group (ISP)
|
Committee, Advisory Group, or Work Group
|
ASPE, CDC, CMS, HRSA, SAMHSA
|
NICHD
|
2020
|
|
ICCVAM Ecotoxicology Workgroup (EcoWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2018
|
|
ICCVAM In Vitro to In Vivo Extrapolation Workgroup (IVIVE-WG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
ICCVAM Metrics Workgroup (MWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD
|
2019
|
|
ICCVAM Nanomaterials Workgroup (NanoWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2018
|
|
ICCVAM Public Forum
|
Meeting/ Workshop
|
FDA
|
NCATS
|
2014
|
|
ICCVAM Read Across Workgroup (RAWG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
Identification and Validation of ctDNA Quality Control Materials
|
Resource Development
|
FDA
|
|
2019
|
|
IEEE Reporting Standards for In Vivo Neural Interface Research Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2018
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Imaging Core Unit
|
Research Initiative
|
FDA
|
NEI
|
|
|
Immune Responses to Influenza Vaccination
|
Research Initiative
|
FDA
|
NIAID
|
|
|
ImmuneChip+ Area of Interest (AOI)
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID, NCATS
|
2022
|
|
Immunology Interest Group
|
Meeting/ Workshop
|
FDA
|
NIDDK, NHLBI, NIAID, NINDS, NIEHS, CC, NIAMS, NEI, NIDCR, NICHD, NIAAA, NIMH, NHGRI, NCCIH, NIA, NIDA, NIDCD, NIGMS, NIMHD, OD/ OIR
|
1990
|
|
Impact of Opioid-Related Emergencies on First Responders
|
Research Initiative
|
FDA
|
CC
|
|
|
Implementation Research in HRSA Ryan White Sites: Screening and Treatment for Mental and Substance Use Disorders to Further the National Ending the HIV Epidemic (EHE) Goals
|
Research Initiative
|
HRSA
|
NIDA
|
2020
|
|
Improving Genomics/Omics Technical Standards and Molecular Tools for Prebiotic Probiotic Research and Development Working Group
|
Research Initiative
|
CDC, FDA, OS
|
NCCIH, NCI, NHGRI, NIDA, NLM
|
2016
|
|
Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)
|
Other
|
FDA
|
NIAID
|
2019
|
|
In Silico Screening for Cancer Targets
|
Research Initiative
|
FDA
|
NCI
|
|
|
In Vitro Assessment of Dermal Hypersensitivity: Using Alternative Methods to Predict Skin Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2018
|
|
In Vitro Assessment of Respiratory Hypersensitivity: Using Alternative Methods to Predict Respiratory Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2022
|
|
Industrywide exposure assessment study of workers exposed to graphene and other two-dimensional nanomaterials
|
Research Initiative
|
CDC
|
NIEHS
|
2018
|
|
Influenza Diagnostics Risk Management Meeting (FRMM) Strategy Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2018
|
|
Influenza Risk Management Meeting
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Influenza Viral Pathogenesis
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Inhibition Of Renal Injury
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Innovation Equity Forum Steering Committee (IEF SteerCo)
|
Research Initiative
|
FDA
|
OD, NICHD, NHLBI, NINDS, NIGMS, FIC, NCATS, NIA, NCCIH
|
2022
|
|
Integrated Research Facility at Fort Detrick
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Inter-Agency Working Group on the National Healthcare Quality and Disparities Report
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, HRSA, IHS, OS, ASPE, FDA
|
NCI, NHLBI, NIMHD, OD/ DPCPSI
|
2015
|
|
Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
CC, NCATS, NCI, NEI, NHGRI, NIAAA, NICHD, NLM, NIA
|
2013
|
|
Interagency Adult Literacy Research Group
|
Committee, Advisory Group, or Work Group
|
ACF
|
NICHD
|
2014
|
|
Interagency Agreement NTP/NIEHS and NCTR/FDA (IAA)
|
Other
|
FDA
|
|
1993
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NICHD, NIEHS, NINDS, NIDCD, OD
|
2000
|
|
InterAgency Board (IAB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
NIEHS
|
2010
|
|
Interagency Cancer Diagnostic Devises Task Force for Near-Patient Use (CD2)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, HRSA
|
|
2019
|
|
Interagency Chemical Risk Assessment Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
NIAID, NINDS
|
2010
|
|
Interagency Collaborative Animal Research Education (ICARE) Training Project
|
Training Initiative
|
CDC, FDA, ASPR
|
OD/ OER
|
2016
|
|
Interagency Collaborative to Advance Research in Epilepsy (ICARE)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH, NINDS
|
2003
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NICHD, NIDCD, NIMH, NINDS
|
1988
|
|
Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OASH, Other
|
NCI, OD/ DPCPSI/ ODS, NICHD
|
2013
|
|
Interagency Committee on Smoking and Health
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, SAMHSA
|
NCI, NIDA
|
1985
|
|
Interagency Committee on the American Community Survey (ACS)
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, HRSA, OS
|
NICHD
|
2005
|
|
Interagency Comparative Genomics Interest Group
|
Meeting/ Workshop
|
CDC
|
|
|
|
Interagency Coordinating Committee for Newborn Screening
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
2008
|
|
Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, ASPE, ASPR, ATSDR, CDC, CMS, HRSA, IHS, SAMHSA
|
NIMH, NIDA, NICHD
|
1996
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt - Jakob disease
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NINDS, NIDDK
|
1985
|
|
Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, IHS, OS, SAMHSA, OASH
|
NIAAA, NIDA
|
2004
|
|
Interagency Coordinating Committee on the Validation of Alternative Toxicological Methods (ICCVAM)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA, CDC
|
NCI, OD, NLM
|
2003
|
|
Interagency Elder Justice Working Group (EJWG)
|
Committee, Advisory Group, or Work Group
|
ACL
|
NIA
|
2016
|
|
Interagency Filovirus Team
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2019
|
|
Interagency Group for Development of Lung Infection Models for P. aeruginosa and A.baumannii
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Interagency Group on Alzheimers Disease and Related Dementias for implementation of the National Alzheimers Project Act
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, AoA, ASPE, ACF, IHS, OASH, SAMHSA
|
NIA
|
2011
|
|
Interagency Group on SARS-CoV-2 Evolution and Vaccine Cadence
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, HIS, SAMHSA
|
NIAID
|
|
|
Interagency Modeling and Analysis Group (IMAG)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, ASPR, Other
|
CSR, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR, FIC
|
2003
|
|
Interagency Morphine Milligram Equivalent (MME) Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIDA
|
2022
|
|
Interagency Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2020
|
|
Interagency Oncology Task Force Fellowship: Track 4
|
Training Initiative
|
FDA
|
|
2005
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
CDC, AHRQ, FDA, SAMHSA
|
NINDS
|
2011
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
NCCIH, NIDA, NIDCR, NINDS, NINR
|
2011
|
|
Interagency Pediatric Surge Working Group
|
Committee, Advisory Group, or Work Group
|
NIH, CDC, HRSA, ASPR
|
NICHD
|
|
|
Interagency Policy Council on Nutrition (IPC)
|
Committee, Advisory Group, or Work Group
|
FDA, CMS, IOS, OASH, ACL, AHRQ, ASFR, ASPE, ASPR, CDC, HRSA, IHS, NIH, OS, SAMHSA
|
NCI, NHLBI, NICHD, NIDDK
|
2021
|
|
Interagency Rehabilitation and Disability Research Portfolio (IRAD)
|
Resource Development
|
ACL, CDC
|
|
|
|
Interagency Select Agent Review Group (ISARG)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NIAID, OD/ OM/ OB, OD/ OSP
|
2011
|
|
Interagency Task Force on the Arts and Human Development
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, SAMHSA
|
NCCIH, NCI, NIA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2011
|
|
Interagency Task Force on Trauma-Informed Care
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NICHD
|
2018
|
|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Research Initiative
|
ACL, CMS, FDA
|
NCI, NHLBI, NIA, NIBIB, NINDS, NINR
|
2014
|
|
Interagency Working Group (IWG) on Communicating Hazard Information and Other Types of Uncertainty, White House Office of Science and Technology Policy (OSTP) Subcommittee on Social and Behavioral Sciences (SBS)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ DPCPSI/ OBSSR, NCI, NIMHD, NINR, NCATS
|
|
|
Interagency Working Group in the Glycosciences
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Interagency working group on Biological Data Sharing (IWGBDS)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIGMS
|
2018
|
|
Interagency Working Group on Harmful Algal Bloom and Hypoxia Research and Control Act (IWG-HABHRCA)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2014
|
|
Interagency Working Group on Scientific Collections of the National Science and Technology Council (IWGSC)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, OD
|
2006
|
|
Interdepartmental Health Equity Collaborative (formerly FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR
|
2006
|
|
Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC)
|
Committee, Advisory Group, or Work Group
|
CMS, SAMHSA
|
|
2018
|
|
Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC)
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
NIDA
|
2019
|
|
International Cancer Control Partnership (ICCP)
|
Other
|
CDC
|
|
2012
|
|
International Cancer Screening Network (ICSN)
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2006
|
|
International Neonatal Consortium
|
Meeting/ Workshop
|
FDA
|
NICHD
|
2015
|
|
International Rare Diseases Research Consortium (IRDiRC) Funders Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCI, NEI, NHGRI, NIAMS, NICHD, NINDS
|
2011
|
|
International TB Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2014
|
|
Interoperability Standards Priorities Task Force of the Health Information Technology (HIT) Standards Committee
|
Committee, Advisory Group, or Work Group
|
ONC
|
|
2016
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NIAID, OD/ ORS, OD/ OSP
|
2005
|
|
Iodine Initiative
|
Resource Development
|
FDA, CDC
|
NICHD, OD/ DPCPSI/ ORWH
|
2011
|
|
Its a Noisy Planet. Protect Their Hearing® Public Education campaign
|
Public Education Campaign
|
CDC
|
NIDCD
|
2008
|
|
JDRF/NIH Beta Cell Replacement Workshop
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDDK, NIAID
|
2021
|
|
Joint Agency Microbiome Working Group (JAM)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ DPCPSI/ ONR, NCI
|
2017
|
|
Joint Agency Nutrition Working Group (JAN)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NCI, OD/ OSP
|
2016
|
|
Joint External Evaluation Working Group (JEEWG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NIEHS, NINDS, OD/ ORS, OD/ OSP
|
|
|
Joint Fellowship Program
|
Training Initiative
|
FDA
|
|
2005
|
|
Justice40/Environmental Justice Stakeholder Engagement Meeting
|
Meeting/ Workshop
|
ASPR, OASH, CDC, HRSA
|
|
2021
|
|
Kaposi Sarcoma and HHV8 in Sickle Cell and Other Ugandan Populations
|
Research Initiative
|
CDC
|
|
2004
|
|
Kidney Innovation Accelerator (KidneyX)
|
Research Initiative
|
FDA, OASH, ASPR
|
NCATS, NIBIB
|
2018
|
|
Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee (KUHICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCCIH, NCI, NHLBI, NIA, NICHD, NINDS, OD/ DPCPSI/ OBSSR, NIDDK
|
1987
|
|
Know Stroke
|
Public Education Campaign
|
CDC
|
|
2001
|
|
Laboratory Services Section, Department of Transfusion Medicine Core Report
|
Research Initiative
|
FDA
|
CC
|
|
|
Leprosy Research Support in Armadillos (Dasypus Novemcinctus)
|
Other
|
HRSA
|
NIAID
|
2002
|
|
Leveraging Novel Technologies for Chronic Disease Management for Aging Underserved Populations
|
Research Initiative
|
OASH
|
NHLBI
|
2020
|
|
LGBT Healthy People 2030 Working Group (LGBT HP 2030)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NINDS, OD/ DPCPSI/ SGMRO
|
2019
|
|
Linkage of Surveillance, Epidemiology, End Results data to Centers for Medicare and Medicaid data (SEER-CMS)
|
Resource Development
|
CMS
|
|
1992
|
|
Liquid Biopsy Working Group (LBWG)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
|
2021
|
|
Logical Observation Identifiers Names and Codes (LOINC)
|
Resource Development
|
AHRQ, CDC, CMS, HRSA, IHS, IOS
|
|
2003
|
|
Long-Term Impact of Military-Relevant Brain Injury (LIMBIC) Consortium/Chronic Effects of Neurotrauma Consortium (GENC) Government Steering Committee
|
Committee, Advisory Group, or Work Group
|
ACL
|
|
2019
|
|
Lower Limb Prosthetics Research Standards Working Group
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CMS, FDA
|
NIDDK, NICHD, OD
|
|
|
Lupus Clinical Trials
|
Research Initiative
|
FDA
|
NIAMS
|
|
|
Lupus Federal Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
NCCIH, NEI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2003
|
|
Lyme and Tick-borne Diseases Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS, CMS
|
NIAID
|
2011
|
|
Macaque models for preclinical development of iPSCs
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
Machine learning methods for literature data extraction
|
Research Initiative
|
FDA
|
|
2018
|
|
Magnetic Resonance Spectroscopy Core Facility
|
Research Initiative
|
FDA
|
NIMH
|
|
|
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
|
Resource Development
|
ASPE, FDA
|
|
2021
|
|
Mapping of the Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT) and International Classification of Disease (ICD) Clinical Terminology
|
Resource Development
|
CDC, IOS
|
|
2004
|
|
Maternal Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NHLBI, NICHD, NIMHD, OD/ DPCPSI/ ORWH
|
2019
|
|
Measuring Efficacy in Neonatal Clinical Trials
|
Meeting/ Workshop
|
FDA
|
|
|
|
Mechanobiology
|
Research Initiative
|
FDA
|
NIBIB
|
|
|
Medical Expenditure Panel Survey (MEPS): Experiences with Cancer Survivorship Supplement (MEPS CSAQ)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC
|
OD/ DPCPSI/ OBSSR
|
2016
|
|
Medical Imaging & Data Resource Center (MIDRC)
|
Resource Development
|
FDA
|
NCI, CC, NCATS, NHLBI, NLM
|
2020
|
|
Memorandum of Understanding (MoU) between FDA/Center for Drug Evaluation and Research (CDER) and NIH/NINDS
|
Other
|
FDA
|
|
2019
|
|
Memorandum of Understanding (MOU) between the FDA Center for Devices and Radiological Health and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2015
|
|
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2002
|
|
Microphysiological Systems for Drug Efficacy and Toxicity Testing (Tissue Chip for Drug Screening)
|
Research Initiative
|
FDA, ASPR
|
NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC
|
2012
|
|
Mind Your Risks
|
Public Education Campaign
|
CDC, CMS
|
NINDS
|
2015
|
|
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Molecular approaches to understand vector-host and vector-pathogen interactions
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Molecular Immunohematology in Ethiopian Sub-populations
|
Research Initiative
|
FDA
|
CC
|
|
|
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Molecular Profiling of Diabetes and its Complications
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Monthly Zika Vaccine Development Meeting
|
Resource Development
|
BARDA, FDA
|
NIAID
|
2018
|
|
Mortality Disparities in American Communities (MDAC) Study
|
Research Initiative
|
CDC, FDA
|
NCI, NIA
|
1985
|
|
MOU with FDA in Clinical Proteomics
|
Resource Development
|
FDA
|
|
2022
|
|
Multiagency Data Initiatives to Build Data Capacity for Patient-Centered Outcomes Research for COVID-19
|
Resource Development
|
AHRQ, ASPE
|
NCATS
|
2021
|
|
Multiple Chronic Conditions eCare Plan Project
|
Resource Development
|
AHRQ, ASPE
|
NIDDK
|
2019
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2002
|
|
My Family Health Portrait (MFHP)
|
Resource Development
|
CDC
|
NCI, NHGRI
|
2005
|
|
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
Research Initiative
|
FDA
|
NINDS
|
|
|
MyHealthfinder Steering Committee
|
Committee, Advisory Group, or Work Group
|
ODPHP, OASH, AHRQ, CDC, HRSA, FDA, CMS, SAMHSA
|
NCI, NIA
|
2021
|
|
Nanotechnology Characterization Laboratory (NCL)
|
Research Initiative
|
FDA
|
|
2004
|
|
NAPA Federal Subgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, ACL, CDC, CMS, FDA, HRSA, IHS
|
NINDS
|
2014
|
|
NASEM Aging Disability and Independence Forum
|
Committee, Advisory Group, or Work Group
|
ACL
|
|
2014
|
|
NASEM Forum on Drug Discovery, Development, and Translation
|
Committee, Advisory Group, or Work Group
|
FDA, ASPR
|
NINDS, NIAID, NCI, NIMH, OD/ OSP, NCATS
|
|
|
NASEM Forum on Neuroscience and Nervous System Disorders
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NIMH, NIAAA, NIA, NIEHS, NIDA
|
2006
|
|
NASEM Forum on Traumatic Brain Injury
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NICHD, NIA
|
2022
|
|
National Academy of Medicine Committee on Emerging Science, Technology, and Innovation in Health and Medicine
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2020
|
|
National Action Alliance for Suicide Prevention (NAASP)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIAAA, NIDA, OD/ DPCPSI/ OBSSR
|
2010
|
|
National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) 2020-2025
|
Committee, Advisory Group, or Work Group
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
2019
|
|
National Action Plan for the Elimination of multi-drug resistant Tuberculosis (MDR TB)
|
Other
|
CDC
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA
|
2015
|
|
National Advisory Board for Medical Rehabilitation Research
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NHLBI, NIA, NIAMS, NICHD, NIDCD, NINDS, OD/ DPCPSI
|
1991
|
|
National Advisory Committee on Children and Disasters (NAACD)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, ASPR
|
NICHD, NIEHS
|
|
|
National Amyotrophic Lateral Sclerosis Registry (National ALS Registry)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NINDS
|
2011
|
|
National Asthma Education and Prevention Program
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
1989
|
|
National Biodefense Strategy - Vaccines Joint Capabilities Plan writing group
|
Other
|
ASPR, CDC, FDA
|
NIAID
|
2022
|
|
National Cancer Control Strategy
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2017
|
|
National Center for Advancing Translational Sciences (NCATS) Toolkit for Patient-focused Therapy Development
|
Resource Development
|
FDA
|
NCATS
|
2017
|
|
National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2008
|
|
National Coalition for Oversight of Assisted Reproductive Technologies (NCOART)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
1997
|
|
National Collaborative on Childhood Obesity Research (NCCOR)
|
Research Initiative
|
CDC
|
NCI, NICHD, NHLBI, NIDDK, FIC, NIAMS, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ONR, OD/ ECHO
|
2010
|
|
National Counterintelligence Task Force (NCITF)
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OM
|
2019
|
|
National COVID Cohort Collaborative (N3C)
|
Research Initiative
|
FDA, ASPR, CMS
|
NCATS, NIGMS
|
2021
|
|
National Database for Antibiotic Resistant Organisms (NDARO)
|
Resource Development
|
CDC, FDA
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIDA
|
2016
|
|
National Death Index Linkage Collaboration (NIH-NDI Agreement)
|
Resource Development
|
CDC
|
OD/ DPCPSI/ OBSSR, OD/ IMOD
|
2019
|
|
National Death Index Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NCATS, NCI, NHLBI, NIA, NIAID, NIDA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2018
|
|
National Emerging Contaminant Research Initiative
|
Research Initiative
|
CDC, ATSDR, FDA
|
|
|
|
National Family Health History Group
|
Public Education Campaign
|
CDC
|
CC, NHGRI, OD/ OSP
|
2005
|
|
National Food and Nutrient Analysis Program (NFNAP)
|
Committee, Advisory Group, or Work Group
|
CDC, IHS, FDA
|
NHLBI, NEI, NIA, NICHD, NIDCR, NIDDK, CSR, NIEHS, OD
|
1997
|
|
National Health Interview Survey (NHIS) Cancer Control Supplement
|
Health Survey
|
CDC
|
|
1992
|
|
National Hispanic Science Network (NHSN)
|
Meeting/ Workshop
|
AHRQ, CDC, SAMHSA
|
NIAAA, NIDA, NIMH
|
2001
|
|
National HIV/AIDS Strategy Steering Committee (NHAS)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, HRSA, IHS, SAMHSA, CMS, FDA, ACL, AHRQ
|
NIAID, NIDDK, OD/ DPCPSI/ OAR
|
2021
|
|
National Hospital Care Survey (NHCS) Patient-Centered Outcomes Research Trust Fund (PCORTF) Project
|
Other
|
CDC, SAMHSA, ASPE, FDA
|
NIDA, NIMH
|
|
|
National Institute on Deafness and Other Communication Disorders (NIDCD) Directory of Organizations
|
Resource Development
|
AHRQ, CDC, CMS
|
NIDCD
|
1995
|
|
National Institutes of Health (NIH) Flow Cytometry Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NEI, NHLBI, NIAID, NIAMS, NIDCR
|
2005
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2002
|
|
National Nanotechnology Initiative (NNI) Nanotechnology Signature Initiative on Nanotechnology Knowledge Infrastructure: Enabling National Leadership in Sustainable Design
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIBIB
|
2012
|
|
National Neurological Conditions Surveillance System (NNCSS)
|
Research Initiative
|
CDC
|
NINDS
|
2016
|
|
National PAD Action Plan
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
NIA, NIDDK
|
2018
|
|
National Response Team (NRT)
|
Committee, Advisory Group, or Work Group
|
ASPR, ATSDR, CDC
|
NIEHS
|
2003
|
|
National Robotics Initiative (NRI)
|
Research Initiative
|
CDC
|
NCATS, NEI, NIA, NIBIB, NINR, NICHD
|
2009
|
|
National Science Advisory Board for Biosecurity
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2004
|
|
National Sexually Transmitted Infections (STI) Strategic Plan
|
Committee, Advisory Group, or Work Group
|
OASH, ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID
|
2020
|
|
National Survey of Family Growth
|
Health Survey
|
ACF, CDC
|
NICHD
|
1973
|
|
National Toxicology Board of Scientific Counselors (NTP BSC)
|
Meeting/ Workshop
|
CDC, FDA
|
|
1978
|
|
National Toxicology Program Executive Committee (NTP EC)
|
Meeting/ Workshop
|
ATSDR, CDC, FDA, OASH
|
|
1978
|
|
National Toxicology Program Steering Committee (NTP SC)
|
Meeting/ Workshop
|
CDC, FDA
|
|
2003
|
|
Native American Research Center for Health (NARCH)
|
Research Initiative
|
IHS
|
CSR, NCI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, NCCIH, NHGRI, NHLBI
|
2000
|
|
Natural Experiments and Effectiveness Studies in the Prevention and Control of Diabetes (NEXT-D/NEXT-D 2.0/NEXT-D3)
|
Research Initiative
|
CDC
|
NIDDK
|
2010
|
|
NBS Implementation Plans Joint Capabilities Plans-Clinical Research Capacity, Therapeutics
|
Committee, Advisory Group, or Work Group
|
FDA, ASPR
|
NIAID
|
2022
|
|
NCATS N3C Collaboration
|
Resource Development
|
FDA
|
NCATS
|
2020
|
|
NCCOR- National collaborative for childhood obesity research
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR
|
2019
|
|
NCHS-CDC NHANES, Dietary Supplements and Selected Nutritional Biomarkers
|
Research Initiative
|
CDC
|
|
1999
|
|
NCHS-CDC NHIS Hearing Supplement
|
Health Survey
|
CDC
|
NIDCD
|
2022
|
|
NCHS-CDC NHIS Taste & Smell and NHIS Voice, Speech, and Language Questionnaire Supplements
|
Health Survey
|
CDC
|
NIDCD
|
2021
|
|
NCHS-CDC-NHANES, Audiometry, Balance, and Words in Noise Component
|
Health Survey
|
CDC
|
NIDCD
|
2018
|
|
NCI Cancer Data Standards Repository and Registry (caDSR)
|
Committee, Advisory Group, or Work Group
|
FDA, ASPE
|
CIT, NEI, NHLBI, NIAMS, NIBIB, NICHD, NIMH, NINDS, NLM, NIDA, NIDCD, NCATS
|
2000
|
|
NCI Cervical Cancer "Last Mile" Initiative (LMI)
|
Research Initiative
|
FDA, CDC
|
|
2021
|
|
NCI Clinical Trials and Translational Research Advisory Committee (CTAC)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
|
2007
|
|
NCI Enterprise Vocabulary Services (EVS) controlled terminology and standards development in collaboration with FDA and international regulatory agencies including NCI/FDA Memorandum of Understanding for Drug Related Information
|
Resource Development
|
FDA
|
|
2012
|
|
NCI Fecal Microbiota Transplants and Defined Microbiota Cancer Therapeutics Clinical Research Working Group/NCI Convenes Workshop on Reproducibility of Fecal Microbiota Transplants in Cancer Therapeutics
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2019
|
|
NCI Multi-Cancer Detection (MCD) Trial Team
|
Research Initiative
|
CMS, FDA
|
OD/ DPCPSI/ ORWH
|
2021
|
|
NCI/CCR-FDA Clinical Investigator Program
|
Research Initiative
|
FDA
|
|
2015
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
|
2007
|
|
NEHEP Partnership Summit
|
Meeting/ Workshop
|
OASH
|
|
2022
|
|
NEI-FDA-ONC Joint Workshop on Promoting Adoption of Ocular Imaging Standards
|
Meeting/ Workshop
|
ONC, FDA
|
|
2021
|
|
Networking and Information Technology Research and Development (NITRD) Program
|
Committee, Advisory Group, or Work Group
|
AHRQ, ONC, CDC
|
NLM, NHGRI, NIBIB, NCI, NCATS, NIGMS, OD/ DPCPSI/ ODSS
|
1991
|
|
Newborn Screening Coding and Terminology Guide
|
Resource Development
|
CDC, FDA, HRSA, IOS, AHRQ
|
NHGRI, NHLBI, NICHD
|
2007
|
|
Newborn Screening Federal Partners Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD, NHGRI, NLM
|
2009
|
|
Next Generation Microfluidics Workshop
|
Meeting/ Workshop
|
FDA
|
|
2021
|
|
NF-kappaB in pathogenesis and therapy of head and neck cancer
|
Research Initiative
|
FDA
|
NICHD
|
|
|
NGSP (formerly the National Glycohemoglobin Standardization Program) (NGSP)
|
Resource Development
|
CDC
|
CC, NIDDK
|
1996
|
|
NHAS Quality of Life Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA, ACL
|
NIMH, NIAID
|
2022
|
|
NIA Confocal Imaging Facility
|
Research Initiative
|
FDA
|
NIA
|
|
|
NIA IMPACT Collaboratory Transforming Dementia Care (IMPACT Collaboratory)
|
Research Initiative
|
CDC
|
NIA
|
2019
|
|
NIAID/Armed Forces Radiobiology Research Institute (AFRRI) Research Coordination Team (RCT)
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2012
|
|
NIAID/CDC Dual Use Research of Concern (DURC) Risk Mitigation Reviews
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2015
|
|
NIAID/FDA/BARDA Meeting on Gastrointestinal Acute Radiation Syndrome (GI-ARS)
|
Meeting/ Workshop
|
FDA, ASPR
|
|
2021
|
|
NIAID/NASA Medical Countermeasures Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NCI, NHLBI
|
2017
|
|
Nicotine Research Cigarettes (SPECTRUM)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
2013
|
|
NIDA-FDA Interagency Clinical Outcomes Assessment Working Group (ICOAWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA, NCI, OD/ DPCPSI/ OBSSR
|
|
|
NIEHS SBIR PHASE IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2016
|
|
NIH Autoimmune Diseases Coordinating Committee (ADCC)
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
NIAID, OD, NCI, NCATS, NCCIH, NEI, NHLBI, NHGRI, NIAMS, NIBIB
|
2003
|
|
NIH Common Data Elements Task Force (CDETF)
|
Committee, Advisory Group, or Work Group
|
AHRQ, FDA, CMS, ASPE, CDC
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NCRR, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODSS, OD/ OER, OD/ AoU, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ SGMRO, OD/ ECHO, NIGMS, NIMH, NIMHD
|
2012
|
|
NIH COVID-19 Treatment Guidelines Panel
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2020
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER
|
2007
|
|
NIH Medical Rehabilitation Coordinating Committee (MRCC)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA
|
CC, CSR, NCCIH, NCI, NEI, NHLBI, NIA, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIMH, NINDS, NINR
|
1999
|
|
NIH World AIDS Day
|
Other
|
OASH
|
NIAID, NIDA, NINDS, NIMH, NCI, NIAAA, NHLBI, NICHD, OD/ DPCPSI/ ODP, NLM, CC
|
2022
|
|
NIH, HUD, CDC Housing and Health Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NICHD, NIDDK, NHLBI, NIEHS, NIMHD, NINR, OD/ DPCPSI/ OBSSR
|
2019
|
|
NIH-FDA Interagency Clinical Outcome Assessments Working Group (ICOAWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ SGMRO
|
2010
|
|
NIH-FDA Medical Device Research Interest Group (MDRIG)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCATS, NCI, NEI, NHLBI, NIA, NIAID, NIBIB, NICHD, NIDDK, NINR, OD/ DPCPSI/ ORIP, FIC, NIAMS, NIDA, NCCIH, NHGRI, NIAAA, NIDCD, NIGMS, NIEHS, NLM, OD
|
2016
|
|
NIH/BARDA Antimicrobial Resistance (AMR) Diagnostic Challenge Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA, CDC
|
NIAID
|
2015
|
|
NIMH-SAMHSA collaboration to support the delivery of evidence based practices in Certified Community Behavioral Health Clinic-Expansion (CCBHC-E) awardees
|
Research Initiative
|
SAMHSA
|
NIDA
|
2021
|
|
NINDS Common Data Elements Program
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
CIT, NINDS, NICHD, NEI, NHGRI, NCATS, NIA, NIMH, NIEHS, NIGMS, NIBIB, NIDDK, NIDCR, NINR, NHLBI
|
2006
|
|
NIOSH SGM Equity Work Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2021
|
|
Nipah viral replicon particle vaccine safety & efficacy evaluation in NHP model
|
Research Initiative
|
CDC
|
NIAID
|
2022
|
|
NITRD Digital Health R&D Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, FDA, ONC
|
NCATS, NHLBI, NIA, NIMH, NIBIB, NICHD, OD/ DPCPSI/ OBSSR, OD/ OSP
|
2011
|
|
Non-animal approaches to assess cardiotoxicity hazard
|
Research Initiative
|
FDA
|
|
2018
|
|
Noroviruses and Epidemic Gastroenteritis
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Notice of Special Interest (NOSI): Priority Research Opportunities in Crisis Response Services
|
Research Initiative
|
SAMHSA
|
|
2021
|
|
Novel Tools and Approaches Research Program
|
Research Initiative
|
ATSDR
|
NIEHS
|
|
|
NSTC Subcommittee on Biological Defense Research and Development - Interagency Bioconvergence Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OSP
|
2020
|
|
NSTC Subcommittee on Biological Sciences
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
|
|
NSTC Subcommittee on Biological Sciences -Interagency Synthetic Biology Working Group (BSSC-SBWG)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIBIB, OD/ OSP
|
2019
|
|
NSTC Subcommittee on Open Science (NSTC SOS)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPR, CDC, FDA
|
OD/ DPCPSI/ ODSS
|
2016
|
|
Nutrition Research Coordinating Committee (NRCC)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, OASH
|
NCATS, NCCIH, FIC, CSR, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC, OD/ ECHO
|
1975
|
|
Obesity Prevention and Control: Combined School-Based Interventions to Increase Healthier Food and Beverage Consumption and Physical Activity
|
Meeting/ Workshop
|
CDC
|
NHLBI
|
2018
|
|
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD)
|
Research Initiative
|
CDC
|
NIAID
|
2018
|
|
Occupational Exposure Assessment of a-Pinene and related Monoterpenes
|
Research Initiative
|
CDC, FDA
|
|
2021
|
|
Occupational Exposure Assessment of Emerging Per- and Polyfluoroalkyl Substances (PFAS)
|
Research Initiative
|
CDC
|
NIEHS
|
2020
|
|
ODP Prevention Scientific Interest Groups (SIGs)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OASH, FDA
|
NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIMHD, NINDS
|
2016
|
|
Office for Human Research Protections/Division of Human Subjects Research
|
Meeting/ Workshop
|
OS
|
OD/ OER
|
2011
|
|
Office of AIDS Research Advisory Council (OARAC)
|
Committee, Advisory Group, or Work Group
|
CDC
|
OD, NIAID, OD/ DPCPSI
|
2007
|
|
Office of Emergency Care (OECR)-FDA Update Meetings
|
Meeting/ Workshop
|
FDA
|
|
|
|
Office of National Drug Control Policy (ONDCP) Data Interagency Working Group (DIWG)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASPE, CDC, CMS, FDA, IHS, NIH, ONC, SAMHSA
|
NIDA, NIAAA
|
2021
|
|
Office of Secretary, Patient-Centered Outcomes Research Trust Fund (OS-PCORTF) PCORTF Projects titled, Data Capacity for PCOR through eCare Planning for People with Multiple Chronic Conditions Disability.
|
Other
|
ACL, AHRQ, IHS
|
NCI, NHLBI, NIA, NIDDK, NLM
|
2017
|
|
Office of the Clinical Director Clinical Services Research
|
Research Initiative
|
IHS
|
NIMH
|
|
|
Older Individuals Collaborative Nutrition Group (OICN)
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, NIH, OASH, OS, ACL
|
NIA, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ONR
|
2021
|
|
ONDCP Harm Reduction Interagency Workgroup
|
Committee, Advisory Group, or Work Group
|
SAMHSA, ASPE, CMS, HRSA, CDC
|
NIDA
|
2022
|
|
ONDCP Methadone Modernization Interagency Workgroup
|
Committee, Advisory Group, or Work Group
|
SAMHSA, HRSA, CMS
|
NIDA
|
2022
|
|
One Health Coordination Unit (OHCU)
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
|
|
Open Science Infrastructure Working Group of the Subcommittee on Open Science of the National Science and Technology Council (OSI)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPR, CDC, FDA
|
OD/ DPCPSI/ ODSS, OD/ OSP, OD/ OER
|
2021
|
|
Operation of the COVID-19 Treatment Guidelines Website
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
Opioids & Substance Use: Workplace Prevention & Response
|
Training Initiative
|
CDC
|
OD/ DPCPSI/ ODP
|
2021
|
|
Oral Health Aging: Information for Caregivers
|
Public Education Campaign
|
ACL, HRSA, OASH
|
NIA
|
2018
|
|
Oral Health in America: Advances and Challenges
|
Resource Development
|
OASH, FDA, CMS, CDC, HRSA, IHS, SAMHSA
|
NIAID, NIAAA, NIDA, NCATS
|
2018
|
|
OS-Patient-Centered Outcomes Research Trust Fund (PCORTF) CMS Pilot Data Linkage Projects Discussion
|
Committee, Advisory Group, or Work Group
|
ASPE, CDC, CMS
|
NICHD, NCATS, NIA, NCCIH, NIDDK
|
|
|
P2P on Postpartum Health
|
Meeting/ Workshop
|
AHRQ
|
OD/ DPCPSI/ ORWH, NICHD, NHLBI, NIMHD
|
|
|
P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
2014
|
|
Pain Assessments Web-Based Tool
|
Resource Development
|
CMS
|
CC, NCCIH, NINR, NIDCR, NIDA, NCI, NIA, NICHD, NIAMS, NIMH, NEI, NIGMS, NIDDK, NIAAA, NIMHD, NIBIB, NIDCD, NCATS, NHLBI, FIC
|
|
|
PALM007
|
Research Initiative
|
CDC
|
NIAID
|
2022
|
|
Pandemic Influenza Translational Research and novel universal countermeasure development
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Pandemic Response Team
|
Other
|
ASPR, CDC
|
NIAID
|
2020
|
|
PAR 22-049 'Integrating Biospecimen Science Approaches into Clinical Assay Development' Steering Committee Collaboration
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2020
|
|
Pathogen Detection Project and Interagency Collaboration on Genomics for Food and Feed Safety (Gen-FS)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
|
2015
|
|
Pathophysiological Actions of Anthrax Virulence Determinants
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Pathways to Prevention (P2P) Workshop Program
|
Meeting/ Workshop
|
AHRQ, CDC, ONC, OASH, ASPE, SAMHSA, HRSA, IHS
|
NCATS, NHLBI, NCI, NIMH, NIMHD, NICHD, NINDS, NIA, OD/ DPCPSI/ ORWH
|
2012
|
|
PCC Technical Working Group on PFAS
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
|
|
|
PCORTF Frailty Functional Disabilities Project Working Group
|
Research Initiative
|
ASPE, AHRQ, CDC, CMS
|
|
2019
|
|
Pediatric COVID-19/MIS-C Interagency Team
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, ASPR
|
NICHD, NHLBI, NIAID
|
2020
|
|
Pediatric Radiation Medical Countermeasures Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
NICHD
|
2022
|
|
Persistent Identifiers subgroup of the Subcommittee on Open Science of the National Science and Technology Council
|
Committee, Advisory Group, or Work Group
|
ACL
|
OD, OD/ DPCPSI/ ODSS
|
2022
|
|
Physiological Effects of Natural or Contaminating Compounds in a Rodent's Microenvironment
|
Research Initiative
|
FDA
|
NIEHS
|
|
|
Pilot Biosurveillance Working Group - National Biodefense Strategy
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2021
|
|
Population Assessment of Tobacco and Health (PATH) Study
|
Health Survey
|
FDA
|
NIDA
|
2011
|
|
Post-Traumatic Stress Disorder (PTSD)/Trauma Brain Injury (TBI), Suicide Prevention National Research Action Plan (NRAP) Workgroup
|
Committee, Advisory Group, or Work Group
|
OS
|
NIAAA, NIDA, NINDS
|
2012
|
|
Postdoctoral Fellowship in Genomic Science and Health Equity
|
Training Initiative
|
FDA
|
|
2021
|
|
PRAMS Interagency Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, NIH, CMS, HRSA
|
NICHD
|
|
|
Precision Oncology Interest Group (POIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID, NHLBI, NIDDK, NIAMS, NCATS, NINDS, NIBIB, NICHD, NIDCR, OD
|
2021
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Covid Response Team
|
Research Initiative
|
CDC
|
CC
|
2020
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Covid Task Force
|
Research Initiative
|
CDC
|
CC
|
2020
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Foundation
|
Research Initiative
|
CDC
|
CC
|
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Predicting Drug Resistance with Machine Learning
|
Resource Development
|
ASPE
|
NIAID
|
2020
|
|
Pregnancy and Birth to 24 Months Project (P/B-24)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2012
|
|
Pregnant People, Substance Use Disorder and Child Welfare, Sub Interagency Policy Committee (IPC) of the Maternal Health IPC
|
Committee, Advisory Group, or Work Group
|
ACF, ASPE, CDC, HRSA, IHS, SAMHSA, OS, IOS
|
NIDA, NICHD
|
2022
|
|
PregSource® Management Team
|
Public Education Campaign
|
CDC, HRSA
|
NCCIH, NHLBI, NICHD, NIEHS, NIMHD, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2017
|
|
President's Advisory Council for HIV/AIDS (PACHA)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, HRSA, IHS, OASH
|
OD/ DPCPSI/ OAR
|
2016
|
|
President's Emergency Plan for AIDS Relief (PEPFAR) Cervical Cancer Prevention Expert Task Force
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2018
|
|
President's Emergency Plan for AIDS Relief (PEPFAR) Implementation Science/Combination Prevention
|
Research Initiative
|
CDC
|
FIC, NCI, NIAAA, NIAID, NIDA, NIMH, OD/ DPCPSI/ OAR
|
2005
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children (PTFCEH)
|
Committee, Advisory Group, or Work Group
|
ACF, ASPR, CDC, ATSDR, FDA, OASH, SAMHSA
|
NICHD, NHLBI, NIMH, NIMHD
|
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children: Lead Exposures Subcommittee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, OS
|
NHLBI, NICHD, NIEHS
|
|
|
President’s Task Force (PTF) on Environmental Health Risks and Safety Risks to Children: Chemical Exposures (ChEx) Subcommittee
|
Committee, Advisory Group, or Work Group
|
FDA, OASH
|
NIEHS
|
1997
|
|
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2015
|
|
Prevention Research Coordinating Committee (PRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OS, FDA, OASH
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ODS, OD/ OLPA
|
1997
|
|
Probiotic and Prebiotic Working Group [PPWG] (PPWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NIAMS, NIDA, NIDCR, OD/ DPCPSI/ ODS, CC, CIT, CSR, FIC, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OEDI
|
2006
|
|
Production and purification of biological compounds
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Preparedness Against Chemical Threats (PACT) Working Group (PHEMCE PACT Working Group)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|
Public Health Service Technology Transfer Policy Board (TTPB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
OD/ OIR/ OTT, OD/ OSP, OD/ OIR, OD/ OER
|
1994
|
|
Quantitative Biophotonics for Tissue Characterization and Function
|
Research Initiative
|
FDA
|
NICHD
|
|
|
Quantum Barcoding for analysis of Ebola infection
|
Other
|
FDA
|
NIAID
|
2019
|
|
Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic
|
Research Initiative
|
CDC
|
NIMHD
|
2021
|
|
Racial/Ethnic Variation of HPV Type Distribution in High-Grade Cervical Precancers and Invasive Cancers in the United States
|
Research Initiative
|
CDC
|
|
2016
|
|
Radiation and Chemical Defense Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
NIEHS, NIAMS
|
2020
|
|
Radiation Biodosimetry Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2012
|
|
Radiation-Induced Immune Dysfunction Meeting
|
Meeting/ Workshop
|
ASPR
|
NIAID
|
2019
|
|
Radiation-Induced Multi Organ Dysfunction Meeting Planning Group
|
Meeting/ Workshop
|
ASPR
|
NCI
|
2020
|
|
Radiobiology Bioterrorism Research and Training Group (RABRAT)
|
Committee, Advisory Group, or Work Group
|
FDA, ASPR
|
NIAID
|
2003
|
|
Rapid Acceleration of Diagnostics Tech Program (RADx Tech)
|
Research Initiative
|
CMS, FDA, CDC, ASPR
|
NIBIB
|
2020
|
|
Rare Disease Day at NIH
|
Meeting/ Workshop
|
FDA
|
NCATS, NHLBI, NCI, CC, NIAAA, NINDS
|
2011
|
|
Rare Diseases Registry Program (RaDaR)
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center
|
Training Initiative
|
FDA
|
CC, NCI, NIAID, NIDCR, NIDDK, NIMH, NINDS
|
2007
|
|
Recognize, Assist, Include, Support and Engage (RAISE) Family Caregiving Advisory Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIA
|
2018
|
|
Reentry Research Network
|
Committee, Advisory Group, or Work Group
|
ACF, SAMHSA
|
NIDA, OD/ DPCPSI/ OBSSR
|
2012
|
|
Regenerative Medicine Innovation Project Senior Oversight Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NEI, NHLBI, NIA, NIAID, NIAMS, NIDCD, NIDCR, NIDDK, NINDS
|
2018
|
|
Regenerative Medicine Project
|
Research Initiative
|
FDA
|
NIA
|
2017
|
|
Registry-based studies of hematologic malignancy incidence and survivorship
|
Research Initiative
|
FDA
|
|
2019
|
|
Regulation of Virulence Genes in Bordetella pertussis
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
RePORT South Africa
|
Research Initiative
|
CDC, OS
|
NIAID
|
2016
|
|
Research in Diabetes Mellitus, Its Complications, and Obesity
|
Research Initiative
|
IHS
|
|
1965
|
|
Research Operations Supporting the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods
|
Research Initiative
|
ATSDR
|
NIEHS
|
|
|
Retina Network
|
Research Initiative
|
OS
|
NEI, NIDDK
|
2002
|
|
Review Policy Committee (RPC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC
|
CSR, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, NIDCD, OD
|
|
|
Revision of Centers for Disease Control and Prevention (CDC) Guidelines on Hepatitis B
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2011
|
|
Rheumatic and Autoimmune Diseases in Minority Communities
|
Research Initiative
|
FDA
|
NIAMS
|
|
|
Role of Class B Scavenger Receptors in Lipid Metabolism and Inflammation
|
Research Initiative
|
FDA
|
CC
|
|
|
Role of Gs-alpha in pancreatic islet cell growth and function
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Rural Opioid Initiative (ROI)
|
Research Initiative
|
CDC, SAMHSA
|
NIDA
|
2017
|
|
Ruth L. Kirschstein National Research Service Award Program
|
Training Initiative
|
AHRQ, HRSA
|
OD/ OER
|
1985
|
|
RxNorm
|
Resource Development
|
FDA
|
|
2005
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NHLBI, NIAID, NIDCR, NIDDK
|
2009
|
|
Safe to Sleep
|
Public Education Campaign
|
CDC, HRSA
|
NICHD
|
1994
|
|
SAMHSA Recovery Month
|
Public Education Campaign
|
SAMHSA
|
NIDA
|
1989
|
|
SARS-CoV-2 Assay Development, Training, and Standardization
|
Resource Development
|
FDA
|
NIAID
|
2020
|
|
SARS-CoV-2 Assessment of Viral Evolution Program (SAVE)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, ASPR
|
NIAID
|
2021
|
|
SARS-CoV-2 evolution in immunocompromised people
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2022
|
|
SARS-CoV-2 Interagency Group on Resistance to Medical Countermeasures (MCMs)
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC, FDA
|
|
2021
|
|
SARS-CoV-2 Pathogenesis
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)
|
Other
|
CDC
|
NIAID
|
2020
|
|
SARS-CoV-2 Virology Core
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
SARS-CoV-2Interagency Working Group: Therapeutics, Diagnostics, Vaccines. DCR involved in Thx and DX (SIG)
|
Committee, Advisory Group, or Work Group
|
NIH, FDA, ASPR
|
NIAID
|
2021
|
|
SEARCH for Diabetes in Youth (SEARCH)
|
Research Initiative
|
CDC
|
|
2001
|
|
Secretary's Advisory Committee on Infant Mortality
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NICHD
|
1991
|
|
Senior Medical Advisor to Assistant Secretary for Preparedness and Response (ASPR)
|
Committee, Advisory Group, or Work Group
|
OS, IOS
|
|
2004
|
|
Sepsis Interagency Meeting
|
Meeting/ Workshop
|
AHRQ, CDC, CMS
|
CC, NHLBI, NIAID, NICHD, NIGMS
|
2019
|
|
Sequencing Quality Control Phase 2 (SEQC2)
|
Resource Development
|
FDA
|
NLM, CIT, NCI, NHLBI, NIEHS
|
2017
|
|
Serum organochlorine/PCB concentrations and risk of prostate cancer in men from Ghana
|
Research Initiative
|
CDC
|
|
2022
|
|
Serum PFAS concentrations and risk of renal cell carcinoma in the Multiethnic Cohort
|
Research Initiative
|
CDC
|
|
2022
|
|
Severe Maternal Morbidity and Mortality (SMM&M) EHR Data Infrastructure Project
|
Other
|
ONC, CDC, ASPE
|
NICHD, NLM
|
2021
|
|
Sex Differences Meeting Planning Committee
|
Meeting/ Workshop
|
BARDA
|
OD/ DPCPSI/ ORWH
|
2020
|
|
SHIELD Standardization of Lab Data to Enhance Outcomes Research and Value Based Care (SHIELD)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2019
|
|
Sickle Cell Disease Federal Interagency Work Group (SCD FIWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, HRSA, OASH
|
NHLBI
|
2019
|
|
Smokefree.gov Initiative
|
Resource Development
|
CDC, FDA, IHS
|
NIMHD
|
2003
|
|
Social Determinants of Health Interagency Policy Committee (SDOH-IPC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, HRSA, SAMHSA, Other, ASPR
|
|
2021
|
|
Social Determinants of Health Research Coordinating Committee (NIH SDOH RCC)
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
NIMHD, NIA, NINR, NIEHS, NCATS, FIC, NIAMS, NCCIH, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ODP, OD/ DPCPSI/ OBSSR
|
2022
|
|
Society for Prevention Research Annual Conference (SPR)
|
Meeting/ Workshop
|
CDC, ACF
|
NCCIH, NCI, NIDA
|
2017
|
|
Somatic Cell Genome Editing
|
Research Initiative
|
FDA
|
NCATS, NCI, NHGRI, NHLBI, NIAID, NIAMS, NIDDK, NIMH, NINDS, OD/ DPCPSI/ ORIP, NIBIB, NEI, NICHD, NIDA, NIEHS
|
2017
|
|
Special Populations Research Forum, Clinical Research Recommendations Subcommittee (SPRF-CRRC)
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
NINDS, NHLBI, OD/ DPCPSI/ SGMRO, OD/ AoU
|
2022
|
|
State Cancer Profiles
|
Resource Development
|
CDC
|
|
2004
|
|
State of Illinois - Governor Challenge
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
|
2020
|
|
Steering Committee of the Scientific Interest Group in Glycobiology
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Structural Analysis Of Candidate Genes For Type 2 Diabetes and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
STS/ACC TVT Registry
|
Meeting/ Workshop
|
CMS, FDA
|
|
|
|
Studies of the Natural History of Sickle Cell Disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
Subcommittee on Open Science (Formerly Interagency Working Group on Open Science)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASPR, CDC, CMS, FDA
|
NLM, OD/ OER, OD/ OSP
|
2013
|
|
Sudden Death in the Young (SDY) Registry
|
Resource Development
|
CDC, HRSA
|
NHLBI, NINDS
|
2013
|
|
SUDV Medical Countermeasures Acceleration Meeting
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, HIS, SAMHSA
|
NIAID
|
|
|
Support for Implementation of Agency Public Access Policies
|
Resource Development
|
AHRQ, CDC, FDA, IOS, ASPR
|
OD/ OSP
|
2013
|
|
Supporting Early Psychosis Research and Implementation
|
Research Initiative
|
OS, ASPE
|
|
2018
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
Resource Development
|
CDC
|
|
1973
|
|
Synthetic DNA Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
OD/ OSP
|
2018
|
|
Systematic Evidence Review of Trauma Informed Care (TIC)
|
Research Initiative
|
AHRQ
|
|
2022
|
|
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT)
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, SAMHSA
|
|
2003
|
|
Systems Immunology of COVID-19
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
Systems immunology of influenza vaccination responses in healthy COVID-19 recovered individual versus those with no history of COVID-19
|
Research Initiative
|
FDA
|
NIAID
|
2021
|
|
Task Force for Combating Antibiotic-Resistant Bacteria (CARB)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, ASPR
|
NIAID
|
2014
|
|
Taxonomics Methods Using DNA
|
Research Initiative
|
FDA
|
NLM
|
|
|
Technical Expert Panel on the development of Evidence-Based Practice Guide on the treatment of serious mental illness (SMI) in older adults.
|
Meeting/ Workshop
|
SAMHSA
|
|
2021
|
|
The Administration for Strategic Preparedness and Response (ASPR)'s chemical, biological, radiological and nuclear defense subject matter expert team
|
Committee, Advisory Group, or Work Group
|
OS, ASPR
|
NIAID
|
2004
|
|
The APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Steering Committee Meetings
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NIDDK, NIMH
|
2018
|
|
The Biology of HIV Infections
|
Research Initiative
|
FDA
|
NIAID
|
|
|
The contribution folate and vitamin B12 genes to disease.
|
Research Initiative
|
CDC
|
NHGRI
|
|
|
The Environmental Determinants of Diabetes in the Young (TEDDY)
|
Research Initiative
|
CDC
|
NIAID, NICHD, NIEHS, NIDDK
|
2002
|
|
The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM)
|
Research Initiative
|
CDC, FDA
|
NHGRI, NHLBI
|
2010
|
|
The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
|
Research Initiative
|
CDC
|
NIDDK, NHLBI
|
2016
|
|
The Golestan Cohort Study of Esophageal Cancer
|
Research Initiative
|
CDC
|
|
2018
|
|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
|
2012
|
|
The Incidence of Breast and Other Cancers Among Female Flight Attendants
|
Research Initiative
|
CDC
|
|
1998
|
|
The Medical Devices Epidemiology Network (MDEpiNet) TMJ RoundTable (MDEpiNet TMJ RoundTable)
|
Meeting/ Workshop
|
AHRQ, FDA
|
|
2016
|
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
OD/ OSP
|
2001
|
|
The National Ending the HIV Epidemic (EHE) Meeting
|
Meeting/ Workshop
|
CDC, HRSA, OASH
|
NIAID, NICHD, NIDA, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
The NIH Helping to End Addiction Long Term (HEAL) Initiative
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NCATS, NCCIH, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ OSP, OD/ DPCPSI/ OBSSR
|
2018
|
|
The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL)
|
Research Initiative
|
CDC
|
NIAID
|
2014
|
|
The President's Task Force on Environmental Health risks and Safety risks to children; Asthma Disparities working group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, IHS
|
NIAID, NICHD, NIMHD, NINR
|
2012
|
|
The Role of the Scavenger Receptor B Family Proteins (SR-BI, SR-BII and CD36) in Infection and Sepsis
|
Research Initiative
|
FDA
|
CC
|
|
|
The Scientific Registry of Transplant Recipients (SRTR) Visiting Committee
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NIAID
|
2011
|
|
The United States Renal Data System (USRDS)
|
Resource Development
|
CMS, HRSA
|
|
1998
|
|
Therapies for patients with rare tumors and genetic tumor predisposition
|
Research Initiative
|
FDA
|
NCI
|
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Advisory Group, or Work Group
|
CDC, SAMHSA, FDA, CMS
|
FIC, NCI, NEI, NHGRI, CSR, NCCIH, NIAMS, NIMH
|
2003
|
|
Tobacco Product Disease Risks
|
Research Initiative
|
FDA
|
|
2016
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIEHS, OD/ OER
|
2012
|
|
Tobacco Use Supplement to Current Population Survey (TUS-CPS)
|
Health Survey
|
CDC, FDA
|
NIMHD
|
1992
|
|
Toxicology in the 21st Century (Tox 21)
|
Resource Development
|
FDA
|
NCATS, NIEHS
|
2008
|
|
Toxicology in the 21st Century Federal Consortium: NCATS Interagency Agreement, ES-7020-01, Year 11 (Tox21)
|
Research Initiative
|
FDA
|
NIEHS, NCATS
|
2007
|
|
Toxicology in the 21st Century Program (Tox21) - Computational Toxicology
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Toxicology in the 21st Century Program (Tox21) - Systems Toxicology
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Toxin Working Group of the Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2015
|
|
Toxins Assessment Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC, FDA
|
NIAID
|
2019
|
|
Tracking Resistance and Coronavirus Evolution (TRACE)
|
Research Initiative
|
ASPR, CDC, FDA
|
NCATS, NIAID
|
2021
|
|
Training Advisory Committee (TAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ ORIP
|
|
|
Trans-Agency (Medical) Imaging Phantom (TAIP) Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB
|
2021
|
|
Trans-Agency Meeting on Adult Obesity Treatment and Prevention: State of the Science, Research Gaps, and Opportunities for Future Research
|
Meeting/ Workshop
|
AHRQ, CDC, HRSA, OASH
|
NCI, NIDDK, NIAMS, NCCIH, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ OPA
|
2021
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2009
|
|
Trans-HHS program for Multi-System Inflammatory Syndrome in Children (MIS-C) and pediatric SARS-CoV-2 (CARING)
|
Research Initiative
|
CDC, FDA, OASH
|
|
2020
|
|
Trans-NIH Liver Cancer Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIDDK, NIAAA, NIAID
|
2016
|
|
Trans-NIH Mitochondrial Disorders Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIMH, NIA, NIGMS, NICHD, NIEHS, NEI, NIDDK, NCATS, NCI, NHLBI, NIAMS
|
|
|
Trans-NIH Working Group for Objective Measures in Cancer
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NIDDK
|
2017
|
|
Translational Science Interagency Fellowship (TSIF)
|
Training Initiative
|
FDA
|
NCATS
|
2030
|
|
Transplant Cancer Match Study
|
Research Initiative
|
HRSA
|
|
2005
|
|
Trial to Assess Chelation Therapy 2 (TACT2)
|
Research Initiative
|
CDC
|
NCCIH, NHLBI, NIEHS, NIDDK
|
2016
|
|
Trial Transparency via Registration and Results Reporting at NIH ClinicalTrials.gov
|
Resource Development
|
FDA
|
CC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD/ DPCPSI/ OBSSR, OD/ OER, OD/ OLPA, OD/ OSP
|
2000
|
|
Tribal Epidemiology Centers Program
|
Research Initiative
|
IHS, CDC
|
NIMHD, OD/ DPCPSI/ THRO
|
2002
|
|
Tumor Mutational Burden (TMB) Harmonization Project
|
Resource Development
|
FDA
|
|
2018
|
|
U.S. and Canada Human Milk Composition Initiative (HMCI)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, OD/ DPCPSI/ ODS, NIDDK, NCI
|
|
|
U.S. Breastfeeding Coalition (USBC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, HRSA, IHS, OASH
|
NICHD
|
|
|
U.S. FDA Medical Imaging Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2015
|
|
U.S. Preventative Services Task Force (USPSTF), NIH IC Liaison Group
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
NIA, NIAID, NICHD, NIMHD, NINR, OD/ DPCPSI/ OAR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORWH
|
1984
|
|
Unified Medical Language System Metathesaurus (UMLS)
|
Resource Development
|
AHRQ, CDC, CMS, FDA
|
|
1990
|
|
Union for International Cancer Control (UICC)
|
Other
|
OGA
|
|
2011
|
|
United States Government Children in Adversity Working Group (APCCA WG)
|
Committee, Advisory Group, or Work Group
|
CDC, ACF
|
FIC, NICHD, NIEHS, NIMH
|
2011
|
|
United States Government Global Nutrition Coordination Plan
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
2016
|
|
United States Government SARS-CoV-2 Interagency Group (SIG), Genomic Surveillance and Bioinformatics Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2021
|
|
Urine biomarkers and risk of lung cancer in the Sisters Study
|
Research Initiative
|
CDC, FDA
|
|
2019
|
|
Urine biomarkers of tobacco and opium and risk of cancers and heart disease
|
Research Initiative
|
CDC, FDA
|
|
2020
|
|
US Government Health Agencies' Efforts to Address HIV-Related Intersectional Stigma
|
Other
|
CDC, HRSA, IHS, OASH, SAMHSA
|
NIMH
|
2022
|
|
US Preventive Services Task Force (USPSTF)
|
Resource Development
|
AHRQ, CDC, CMS, HRSA, IHS, OASH, FDA, SAMHSA
|
NCI
|
2001
|
|
US Public Health Service (USPHS) Physicians Professional Advisory Committee (PPAC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIAID
|
2015
|
|
USDA-HHS Birth to 24 Months Pregnant Women Project Federal Expert Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR
|
2012
|
|
Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum
|
Research Initiative
|
CDC
|
|
2019
|
|
Vaccines and Related Biological Products Advisory Committee (VRBPAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2018
|
|
Vaccines and Therapeutics for Anthrax
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Validation study of the electrophilic allergen screening assay
|
Research Initiative
|
FDA
|
|
2017
|
|
Value Set Authority Center (VSAC)
|
Resource Development
|
AHRQ, CDC, CMS, IOS
|
|
2012
|
|
Vector-borne pathogen transmission
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
Veterans Affairs Science and Health Initiative to Combat Infectious and Emerging Life-threatening Diseases (VA SHIELD)
|
Other
|
CDC
|
|
2022
|
|
Virology Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NINDS
|
1994
|
|
Virus Ecology Unit
|
Research Initiative
|
CDC
|
NIAID
|
|
|
Vision Research Collaborative
|
Research Initiative
|
FDA
|
NEI
|
2020
|
|
Weighting methods for healthy worker survivor bias
|
Research Initiative
|
CDC
|
|
2022
|
|
White House Gender Policy Council: Science & Technology Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
OASH, FDA
|
NICHD, NCI
|
2021
|
|
WHO Risk Assessment Netword
|
Public Education Campaign
|
CDC
|
|
|
|
Whole Genome and Whole Exome Sequencing to Identify Genes for Type 2 Diabetes and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Why has progress in hypertension control plateaued in the United States, and how can progress be restarted? Establishing a Research Agenda for the 2020s
|
Meeting/ Workshop
|
CDC
|
NHLBI
|
2019
|
|
Working Groups to Develop HIV/AIDS Treatment and Prevention Guidelines
|
Committee, Advisory Group, or Work Group
|
OASH
|
CC, NIAID, NICHD, NLM, OD/ DPCPSI
|
2005
|
|
Workshop on Housing and Obesity: Gaps, Opportunities, and Future Directions for Advancing Health Equity
|
Meeting/ Workshop
|
CDC
|
NIDDK, NHLBI, NCI, OD/ DPCPSI/ ODP, NICHD, NINR, NIMHD
|
2022
|
|
World Cancer Research Day, HPVAware, and World No Tobacco Day, World Cancer Day observances
|
Committee, Advisory Group, or Work Group
|
OGA
|
FIC
|
2017
|
|
World Health Organization (WHO) Programme on Prevention of Deafness and Hearing Loss
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIDCD
|
2017
|
|
World Health Organization Pediatric Antiretroviral Drug Optimization (PADO)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
WTP 2022 Spring Workshop: Preparing Workers for the Impacts of Climate Change through Training
|
Meeting/ Workshop
|
OASH
|
|
2022
|
|
Year of Open Science subgroup of the Subcommittee on Open Science of the National Science and Technology Council
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2022
|
|
ZIA CARCI Carcinogenicity Health Effects innovation Research Program
|
Research Initiative
|
ATSDR
|
NIEHS
|
|
|
|